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CHAPTER 1 
INTRODUCTION AND AIMS OF THE STUDY 
INTRODUCTION 
During the administration of an anesthetic the anesthesiologist 
constantly has to make decisions about the dosage of a number of 
potent drugs. As a basis for these decisions ideally the anesthesiologist 
should be able to constantly compare desired effect with observed 
effect. The desired effect means an unconscious patient without 
awareness and either conscious or subconscious recall and who will 
wake up quickly after cessation of the administration of anesthetic 
drugs. However the assessment of consciousness or awareness during 
anesthesia is still an unresolved problem. 
In recent years drugs for use during anesthesia with high receptor 
specificity have become available. These drugs are short acting and are 
relatively free of side effects. They have brought within reach the 
separate production of some of the requirements of anesthesia, i.e. 
analgesia, unconsciousness and muscle relaxation. For these reasons 
anesthesia by continuous infusion is gaining increasing popularity [IJ. 
In this thesis intravenous anesthetic drugs are investigated. Both a 
potent short acting analgesic -alfentanil- and a short acting hypnotic 
-propofol- are studied. Anesthetic depth in inhalation anesthesia has 
always been monitored by observing clinical signs such as sweating, 
tear formation and the cardiovascular parameters blood pressure and 
pulse rate. Because of the relative lack of side effects, these signs, 
however, are not reliable during intravenous anesthesia, particularly 
during light levels. Therefore to avoid too light anesthesia with the 
possibility of awareness during intravenous anesthesia additional 
techniques for monitoring of anesthetic depth are needed. We chose to 
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investigate the use of two types of neurophysiologic monitoring: 
Somatosensory Evoked Potentials and EEG. We expected modulation of 
the conduction along sensory pathways by the analgesic to become 
detectable in the Somatosensory Evoked Potentials. The effects of the 
hypnotic drug on spontaneous activity of the brain were expected to 
show in the frequency content of the EEG signal. 
AIMS 
We define the aims of this study as follows. 
1. Exploration of two intravenous anesthetic drugs. By testing a 
pure analgesic and a pure hypnotic in separate experiments, 
we try to show the clinical usefulness of both drugs in future 
intravenous techniques. This part of the work will give some 
answers to the question how well these drugs fulfil the criteria 
of steady state intravenous anesthesia. 
2. Testing the possibilities of using Neurophysiological 
monitoring for the assessment of anesthetic depth during 
these two types of intravenous anesthesia. 
3. Efforts to correlate three elements in the determination of 
anesthetic depth during intravenous infusion of these drugs: 
clinical signs, neurophysiological changes and plasma 
concentration. 
REFERENCES 
1. Total Intravenous Anaesthesia. B. Kay ed. 1991; Elsevier Amsterdam, New 
York, Oxford 
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CHAPTER 2 
LITERATURE 
HISTORY 
Techniques of general anesthesia 
From the first days of anesthesia until early in the twentieth century 
general anesthesia was produced by inhalation of a volatile anesthetic 
as a "mono anesthetic" -usually ether or chloroform. The advent of the 
barbiturates marked a gradual change towards anesthetic techniques 
which included intravenous drugs. As early as 1938 the favourable 
interaction of Nitrous Oxide and barbiturates was recognised [1]. Also 
the importance of combining barbiturates with analgesics was stressed 
and nitrous oxide and pethidine were recommended in a number of 
papers [2],[3]. Gradual evolution of these concepts have led to the 
development of five groups of general anesthetic techniques. 
1 Intravenous induction with a hypnotic -which sole effect is to 
produce unconsciousness- or an inhalation induction followed 
by maintenance with inhalation agents. This technique is 
commonly known as "Inhalation anesthesia" 
2 Intravenous induction with a hypnotic followed by a 
combination of a potent analgesic and a high dose of a 
neuroleptic. These techniques are known under the name of 
"Neurolept anesthesia" 
3 Intravenous induction with a hypnotic followed by a 
combination of intravenous analgesics, neuromuscular 
relaxants and sometimes small doses of benzodiazepines or 
neuroleptics supported by artificial ventilation with Nitrous 
Oxide in Oxygen. This is the most widely used form of 
"Intravenous anesthesia" 
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4 Induction and maintenance of anesthesia by high dose 
opioids, usually in combination with a benzodiazepine or 
nitrous oxide. These techniques are commonly called "Narcotic 
anesthesia". 
5 Intravenous induction with a hypnotic and analgesic, followed 
by the same hypnotic, an analgesic and a neuromuscular 
relaxant, all given exclusively intravenously. These techniques 
are grouped under the name "Total Intravenous Anesthesia". 
ad i Inhalation anesthesia is not a subject in this thesis. 
ad2 These techniques originate from the 'lytic cocktail' described by 
Laborit and Hugenard in 1954 [4] [5]. This type of anesthetic 
technique is called "Neurolept". The term Neurolept to indicate the 
combination of potent analgesic and neuroleptic (or tranquillizer) 
drugs was first described by de Castro and Mundeleer in 1959 
[6]. Initially the name Neurolept Analgesia was used to indicate 
that patients were not necessarily unconscious, but gradually this 
term has been used almost indiscriminately with Neurolept 
Anesthesia, and the subtle difference between the neuroleptic and 
anesthetic states has disappeared. 
ad3 These techniques were grouped under the name "Balanced 
Anesthesia". This term was revived and publicized by Gray and 
Rees in 1952 [7] from earlier work by Lundy [8]. 
ad4 The use of morphine as a single anesthetic agent was first 
described by Lowenstein and co-workers in 1969 [91. They used 
it in patients with severe heart disease presenting for cardiac 
surgery. Although the patients did not show any response to 
surgical stimulus, a high rate of awareness was reported. These 
reports led to a search for an improved hypnotic component of the 
technique by addition of other agents, for example a 
benzodiazepine as premedicant, or nitrous oxide peroperatively. 
ad5 In Total Intravenous Anesthesia all drugs are given intravenously. 
Many anesthesiologists consider Total Intravenous Anesthesia as 
an ideal technique because it allows separate control over 
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hypnosis, analgesia and muscle relaxation. Also, with proper use of 
the technique, it allows for faster induction and recovery [10]. 
Anesthetic depth 
Fig. 2.1 
In the literature no perfect definition of anesthetic depth can be found. 
Using the effects of ether as a guide Guedel described his concept of 
stages of general anesthesia around 1937 [11] {Fig.2.11. With the 
introduction into anesthesia of muscle relaxants and of intravenous 
anesthetics the stages of Guedel no longer applied for the following 
reasons. Neuromuscular relaxants posed a particular problem as seven 
of the nine components of Guedel's system involved the gradual 
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abolition of skeletal muscle activity. Barbi turate induct ion can produce 
a s ta te that fulfils the criteria for Guedel 's stage 3, yet when a skin 
incision is m a d e the pat ient will move a s if in stage 2. Woodbridge in 
1957 tried to solve this problem by defining the necessary components 
of general anes thes ia [12]. He concluded t h a t anesthes ia should 
consist of the suppress ion of four c o m p o n e n t s of neuronal activity: 
• Sensory (afferent) pathways. 
• Motor (efferent) pathways. 
• Reflexes (autonomous) 
• Mental (state of sleep or unconsciousness) . 
From these elements he derived the signs t h a t could be interpreted a s 
a n indication of insufficient depth. His paper included the first scientific 
recognition t h a t a rise in pulse rate or blood pressure m a r k s too light 
a n anesthet ic depth. 
Fig. 2.2 
Suppression of responses to noxious stimuli. Ranked from left to right in 
the order in which they are suppressed by general anaesthetics. From Piys-
Roberts С British Journal of Anaesthesia 1987;59:1342. Reproduced with 
permission. 
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In 1987 in an editorial in The British Journal of Anaesthesia Prys 
Roberts gave a reappraisal of the concept of anesthetic depth [13]. 
He defined general anesthesia as a state of absence of perception of 
noxious stimulation as transmitted by the sensory nervous system. 
According to his theory the other three elements mentioned by 
Woodbridge are only secondary to the blocking of sensory (afferent) 
stimulation. Anesthetic depth should then be monitored by observing 
and or monitoring the various responses to noxious (surgical) 
stimulation. (Fig.2.2| 
PRESENT SITUATION 
Intravenous anesthesia 
Definition 
Intravenous anesthesia is anesthesia produced by intravenously 
administered drugs, without the use of volatile anesthetics. In this 
thesis we will make a differentiation between total intravenous 
anesthesia and intravenous anesthesia. In total intravenous anesthesia 
the patient Is ventilated with an air/oxygen mixture; in intravenous 
anesthesia the patient is ventilated with a nitrous oxide/oxygen 
mixture while all other drugs are given intravenously. Nitrous oxide 
contributes both to the analgesic and the hypnotic effects of the 
intravenous drugs. The recent development of powerful drugs with a 
high receptor specificity and favourable pharmacokinetics makes it 
possible to produce all objectives of general anesthesia by selectively 
injecting or infusing separate drugs. This is gradually making 
intravenous anesthesia a clinical reality. The techniques described in 
this thesis could be seen as recent additions to the group of techniques 
formerly called balanced anesthesia, now called intravenous 
anesthesia. 
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Objectives of general anesthesia 
In spite of the new approach by Prys-Roberts, the components of 
general anesthesia as defined by Woodbridge can still serve as the basis 
for the development of an intravenous anesthetic technique. 
• Analgesia 
Providing analgesia is probably the most important task for the 
anesthesiologist since only with adequate analgesia can both mental 
suffering from pain and the potentially harmful stress response to 
surgery be mitigated. In general anesthesia opioids is the group of 
drugs most frequently used to produce the desired analgesia. For the 
purpose of intravenous anesthesia the use of an ultra short acting 
powerful sjmthetic analgesic allows titration of analgesia to the needs of 
the individual patient and to the stage of the surgical intervention 
without prolongation of recovery or postoperative respiratory 
depression. 
• Muscle relaxation 
Muscle relaxation serves two important functions. Firstly it prevents 
reflex muscle contraction upon painful surgical stimulation, making 
surgical access possible to body cavities especially in the case of 
abdominal surgery. Secondly it facilitates intubation and artificial 
ventilation. Through the reduction of sensory input into the reticular 
formation muscle relaxation may play a role in increasing anesthetic 
depth. Pancuronium has been shown by Forbes and coworkers to 
decrease Minimal Alveolar Concentration (=MAC) for Halothane [14]. 
MAC is the minimal concentration in the alveoly of the lung of an 
inhalation agent needed to abolish movement in response to surgical 
incision in 50% of a standard patient population. More research will be 
needed to show the true nature and the importance of this reduction in 
MAC with muscle relaxation. 
• Autonomic reflex suppression 
Tissue damage by surgery or manipulation of internal organs produces 
reflexes mediated through the autonomous nervous system. In 
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intravenous anesthesia suppression of these reflexes is produced by the 
combined effects of sedatives -especially neuroleptic drugs- , hypnotics 
and analgesics. The addition of specific drugs such as the vagolytics 
atropine or glycopyrrolate and alpha and beta adrenergic blocking 
drugs may sometimes be helpful or even necessary. 
• Unconsciousness 
Unconsciousness in the context of general anesthesia is a state of the 
central nervous system of reversible suppression of its response to 
external and internal sensory input. Drugs that have as their main 
effect to cause unconsciousness are commonly called hypnotics. In 
intravenous anesthesia unconsciousness is produced and maintained 
by a combination of effects from various drugs. In the context of total 
intravenous anesthesia a continuous infusion of a pure hypnotic will 
produce sleep which is enhanced by sedative effects from narcotic 
analgesics and or neuroleptics. Alternatively a high dose of a narcotic 
analgesic will produce heavy sedation or even light sleep which can be 
deepened by combining it with nitrous oxide or a low dose of a 
hypnotic. In this type of narcotic sedation the most important receptor 
involved is the μ opiate receptor, but other receptors including the 
GABA receptor might also be involved [15],[16]. 
Drugs to be used in intravenous anesthesia 
From the literature some of the properties can be distilled that would be 
required to make ideally suitable drug components of an intravenous 
technique. 
The 'ideal' narcotic 
Based on their experience with morphine as an intravenous anesthetic, 
Moldenhauer and Hug [17] stated that the ideal narcotic in a 
narcotic intravenous technique has the following properties: 
• Greater specificity and efficacy than that of existing narcotics. 
This would require higher receptor aflinity. 
• Analgesia without: respiratory depression, nausea or intestinal 
cramping. 
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• Fast onset and short duration of effects. This would allow 
better control over intensity of analgesia as a change in dose 
or infusion rate would quickly show its effect. 
• Non-addictive, lack of tolerance. This becomes more important 
when the duration of (continuous) administration increases. 
The 'ideal' hypnotic 
Based on our own experience in combination with comments given in 
literature we state as some of the properties an ideal hypnotic should 
have. 
• Fast acting with smooth induction. 
Fast onset of action means a fast induction. Rapid transition 
to deeper levels of anesthesia usually mean smooth induction 
with little or no excitatory phenomena. Also an injection or a 
change in infusion rate is quickly followed by a change in 
effect thus allowing titration of effect against need. Ideally the 
effect should start after one circulation time. 
• Short acting with fast recovery. 
Short action of an intravenous drug can mean rapid 
redistribution or a short elimination half life. In both cases the 
effects of the drug will disappear quickly after termination of 
an infusion. A short elimination half life is preferable to only 
rapid redistribution. The reason for this is that for a drug that 
is purely redistributed, significant elimination from the body 
continues after recovery of the patient canying the risk of 
depression of the central nervous system lasting into the 
postoperative period. 
• Specific without side effects. 
High specificity means that the drug has only one principal 
action and thus has few other elfects. Such a drug will mainly 
interact with one type of receptor or one group of receptors. 
This makes the effects of varying doses predictable. 
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• Metabolites 
Metabolites should have no (hypnotic) effect. With prolonged 
infusion of the drug the accumulation of metabolites might 
otherwise prolong hypnotic effect. 
Intravenous versus inhalation anesthesia 
Side effects 
All inhalation anesthetics known to date have side effects particularly 
on the heart and blood vessels. These side effects are dose dependent 
meaning that for an increase in anesthetic effect also inevitably these 
side effects are increased. Recently developed drugs used for 
intravenous anesthesia have been reported to produce much less side 
effects on the circulation. Thus in the range of effects normally used 
these drugs will not neccessarily cause a clinically significant change in 
circulatory variables. 
Recovery 
The newer hypnotic drugs have very short elimination half lives. 
Recovery from intravenous anesthesia can therefore be fast. Especially 
for propofol short recovery times have been published. In one report the 
initial distibution half life, Ла, was calculated at 23.6 min [18]. 
Also the quality of recovery measured with simple cognitive tests was 
described as superior, both in adults and in children [19], [20]. 
Environmental considerations 
All inhalation agents in use today are halogenated carbo-hydrates. 
Whether scavenging of waste gases is used or not, any gases not 
metabolised by the patient are eventually vented into the atmosphere 
thus contributing to pollution. With the increasing acceptance of closed 
or low flow systems this consideration loses some of its importance. 
Occupational hazard 
When inhalation anesthetics are being used all operation theatre 
personnel is continuously exposed to low concentrations. Many studies 
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have shown trace concentrations of nitrous oxide and of volatile 
anesthetics in the working environment of operating theatre personnel. 
In one study 5-10 ppm Halothane was found within a 1 meter radius of 
a semiclosed circle anesthesia circuit [21]. The consequences of this 
type of exposure to low concentrations are as yet not fully clear. A 
number of animal studies and some statistical studies in theatre 
personnel suggest potentially harmful effects [22]. The large number 
of people exposed to a potential occupational hazard warrants attempts 
to eliminate all risks. Expensive systems for scavenging can in part 
solve this problem but exposure will still occur. The use of total 
intravenous anesthesia would avoid these hazards altogether. 
Anesthetic depth 
Definition 
Although a partly intuitive, partly objective assessment of anesthetic 
depth is made by the anesthesiologist as part of patient monitoring in 
every case it is very difficult to give a clear and simple definition of 
anesthetic depth. Anesthetic depth could be described as the level of 
depression of all responses to noxious (surgical) stimulation. This needs 
depression of consciousness, pain perception, muscle responses and 
autonomic reflexes. 
For the purposes of this thesis we will use the following definition: 
Anesthetic depth is the degree of suppression of consciousness and 
responsiveness of the central nervous system to noxious stimulation. 
The ideal indicator of anesthetic depth. 
According to Sebel [23] a good indicator of anesthetic depth should 
fulfil the following requirements: 
1 It should show graded responses to changing anesthetic depth 
at all levels from light sedation to deep surgical anesthesia. 
2 It should be independent of anesthetic technique and respond 
to surgical stimulus when anesthesia is inadequate. 
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3 The indicator should be easily quantified, readily interpreted, 
and be unaffected by such routine operating theatre 
interference as electrocautery and other electrical interference. 
Anesthetic depth in clinical practice 
Muscle response 
During light anesthesia without full muscle relaxation movement in 
response to surgical stimulation is a very important clinical sign of 
insufficient anesthetic depth. Two types of response are seen according 
to increasing depth. First at lighter levels there is either a purposeful or 
an uncoordinated movement of arms or legs. At deeper levels only a 
tightening of facial musculature "frowning" can be noticed. The use of 
movement as indicator of depth was further developed by Tunstall and 
coworkers [24]. Before full curarization of their patients they 
isolated one forearm from the circulation by inflating a tourniquet. They 
then prompted the patient verbally to show awareness by movement of 
the isolated arm. Thus even in the curarized patient movement can be 
used to indicate inadequate anesthetic depth. Subsequent research has 
shed doubt on the accuracy of the isolated forearm technique for the 
detection of awareness [25]. 
Respiration 
When a patient is breathing spontaneously during inhalation 
anesthesia the pattern of respiration is a very important sign of 
anesthetic depth. In the lightest planes of anesthesia breathing is 
irregular, becoming regular and automatic with a fixed 
inspiration/expiration ratio when anesthesia deepens. At the deepest 
levels of anesthesia respiration becomes increasingly depressed, finally 
leading to complete cessation of respiration. In intravenous anesthesia 
the pattern of breathing is mainly determined by the central effect of 
hypnotics and opioids. When breathing becomes progressively 
depressed and the patient has to be ventilated artificially this clinical 
sign is no longer of use. 
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Autonomie response 
According to Prys-Roberts three types of autonomic response to surgical 
stimulation play an important role in the determination of anesthetic 
depth [13]. These are: 
1 Haemodynamic. This response is a consequence of 
sympathetic stimulation leading to peripheral vasoconstriction 
and direct adrenergic stimulation of the heart. Also the 
parasympathetic system can show response to surgical 
stimulation, usually in the form of bradycardia. 
2 Sudomotor. This reflex is characterized by sweating. It is 
produced by sympathetic stimulation. 
3 Hormonal. A number of hormones, amongst others 
catecholamines, insulin and growth hormone are secreted in 
higher concentration under conditions of surgical stress 
[26], [27]. 
The importance of measuring anesthetic depth 
Patient Safety 
Because in intravenous anesthesia clinical signs as mentioned above 
are unreliable, there is always the risk that either too light or 
unnecessary deep levels of anesthesia go unnoticed. Too light an 
anesthesia may lead to awareness with possibly harmful psychological 
effects and to a potentially harmful stress response. Too deep a level of 
anesthesia by drug overdosage gives rise to perioperative side effects 
and prolonged recovery with undesirable depression of respiration and 
circulation. 
Clinical assessment of anesthetic depth in intravenous anesthesia 
Introduction 
The drugs used in intravenous anesthesia do not produce the 
generalised central nervous system depression as the inhalation agents 
do. For example the use of opioids prevents pupillary dilatation. 
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Therefore the stages of anesthetic depth as described by Guedel, can 
not be applied to this type of anesthesia. One of the biggest problems 
remaining is that no monitoring is known to discriminate completely 
between effects of the hypnotic and the analgesic. No clear advice can 
be found in the literature on how to decide which drug to supplement 
when a patient's response to surgical stimuli is observed. 
Clinical observation to assess anesthetic depth in intravenous 
anesthesia consists of a number of observations meant to estimate the 
amount of autonomic nervous stimulation and of observation of other 
signs of response to painful stimulation. Autonomous stimulation can 
be assessed by measuring changes in blood pressure and heart rate 
and by looking for sweating and signs of peripheral vasoconstriction. 
Signs of reaction to pain are movement of extremities, eyebrow 
movement and lachrymation. All these signs combine to give an overall 
impression that is in part intuitively interpreted by the experienced 
anesthesiologist to arrive at an estimate of anesthetic depth. 
Circulation 
Circulatory side effects are much less with intravenous agents than 
with inhalation agents. Also effects of intravenous agents on the 
circulation do not always show a linear dose effect relationship. 
Therefore depression of blood pressure and/or cardiac output alone 
cannot be employed for objective determination of the anesthetic depth 
during intravenous anesthesia. 
Muscle response 
Neuromuscular relaxants form part of most techniques of general 
anesthesia. When the capability of the patient to use skeletal muscles 
changes throughout the procedure, this prevents patient movement to 
be used as a consistent measure of anesthetic depth. 
Respiration 
The change in respiratory pattern and respiratory rate produced by 
narcotic analgesics makes respiration an unreliable parameter for 
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assessment of anesthetic depth in intravenous anesthesia. Paralysis of 
respiratory musculature with neuromuscular relaxants as is the case in 
most intravenous techniques precludes it altogether. 
Autonomic response 
Autonomic reflex suppression by intravenous drugs and/or the use of 
autonomous nervous system blocking drugs makes the use of a rise in 
pulse rate and blood pressure less reliable in the prediction of light 
levels of anesthesia as reports of awareness during anesthesia have 
shown [28]. 
Techniques for monitoring anesthetic depth in intravenous 
anesthesia 
Neurophysiology 
Monitoring of anesthetic depth in intravenous anesthesia should take 
into account the fact that separate drugs are being used to produce the 
desired effects. The description of the concept of anesthetic depth as 
defined earlier in this chapter explains why we feel that any type of 
monitoring should at least consist of tests of depression of 
consciousness and of pain response. Both drug actions involve the 
central nervous system. That is why in this thesis we concentrate on 
techniques of monitoring central nervous system activity for objective 
assessment of anesthetic depth. 
Plasma concentration 
Modem hypnotics and analgesics are all drug with good lipid solubility 
and rapid penetration of the blood-brain barrier. This means that there 
is a good correlation between drug effect and concentration in the 
plasma. It would even be more ideal if concentration could be measured 
at the target receptor, but this is for the time being impossible. The only 
drawback with the use of plasma concentration as gauge of anesthetic 
depth is that estimation of drug concentration can only be performed 
off line, which is a time consuming process. This method finds at 
present only use as a posteriori check of other on line measurements or 
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as check of computer prediction in open loop controlled infusion. 
Developments of immuno essay in combination with ion sensitive field 
effect transistor techniques might in future offer the possibility of on 
line plasma concentration measurement [29]. 
Neurophysiological monitoring 
As defined above anesthetic depth is derived from the absence of 
responses. All responses are elicited through the central nervous 
system. From there it follows that a monitor of anesthetic depth should 
measure the suppression of the central nervous system caused by the 
drugs used. 
In clinical neurophysiology techniques for monitoring spontaneous and 
evoked electrical activity from the central nervous system have been 
developed. These signals can give an indication of the level of 
spontaneous or evoked activity of central nervous system structures. 
For any form of neurophysiological monitoring to be of value as a 
monitoring tool for anesthetic depth it is necessary that the result be a 
real time signal and can easily be interpreted by the anesthesiologist. 
Preferably the result must be in a form that allows for quantitative 
measurement. It has been the advent of mini- and microcomputers that 
has made it feasible to perform real time analysis of neurophysiological 
signals. 
We will continue by looking in more detail into the techniques employed 
in clinical practice. 
Types of neurophysiological monitoring 
Electroencephalogram 
The Electroencephalogram (EEG) is formed by the spontaneous 
potential changes of neurones in the cerebral cortex recorded by 
surface electrodes from the scalp. Using the raw EEG signal to measure 
anesthetic depth presents a problem. The most common form of 
processing is visual assessment of amplitude, frequency content and 
change in time of the signal. To perform this kind of evaluation a great 
deal of expertise is needed. Most important, the raw signal has too high 
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a content of information to allow on line visual quantification of 
anesthetic depth. Therefore methods to reduce the complexity of the 
signal and to simplify the presentation of relevant information 
contained in the EEG have been developed. These methods are based 
on data reduction and data compression. 
Methods of data reduction 
A commonly employed technique of EEG monitoring in the operating 
room uses two channnels of EEG, one from each hemisfere. This 
supposes that the changes produced during anesthesia are global, not 
focal. This means that enlarging the area of brain under a pair of 
electrodes does not make the information invalid. The amplitude, 
frequency and time domains are combined and often compressed to 
derive a visually identifiable tracing that represents electrical activity 
per lead over a fixed period of time. A clear review of techniques of data 
reduction was given by Levi et al in 1980 (30]. At present the most 
important means for data reduction is a mathematical technique called 
Fast Fourier Transform (FFT). FFT is a computer algorithm for the 
Fourier power spectrum analysis. It can be performed in microseconds 
by a microcomputer and calculates the power of all sinus wave 
components that add up to reproduce the original signal of an epoch of 
EEG. 
Data compression 
The resultant data stream from the Fourier Transformation is often 
further compressed to obtain an image of change over time that can 
easily and quickly be interpreted. The plot of power against frequency is 
smoothed and presented in graphical form where the data related to 
subsequent epochs are plotted with an upward shift. Parts of the 
previous spectrum that fall behind the next spectra are not plotted 
according to a hidden line suppression algorithm. A plot results of 
consecutive EEG epochs where frequencies representing significant 
power in the raw EEG show up as quasi mountains. Such a plot is 
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Fig. 2.3 
Formation of the compressed spectral array (CSA). From Levy WJ et al 
Automated EEG processing for intraoperative monitoring. Anesthesiology 
1980:53:227. Published with permission. 
A Successive Power Spectra. 
В Spectra are plotted with small vertical displacement indicating time. 
С Hidden line suppression algorithm is employed. 
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Fig. 2.4 
Problems with the linear display of the spectral analysis (CSA). 
1) Loss of data. An epoch of high-amplitude acivity is shown obscuring part 
of the data in subsequent epochs for almost 3 mm. Any changes in the 0-7 
Hz range of the EEG during this time would not be detectable. In an effort 
to prevent an even greater loss of data when very high amplitude activity 
occurs "hills" may be truncated, as indicated by the heavy horizontal lines. 
Unfortunately, this only changes the nature of the data lost, it does not 
prevent the loss. 
2.) Confusion of time and amplitude. Because time and amplitude of the 
EEG spectrum are displayed on the same axis, an identifiable baseline is 
needed to estimate the amplitude. The low-amplitude, high-frequency 
segment of the epoch often serves as such a baseline; however, in areas 
such as those identified by the hollow arrows, it may be difficult or 
impossible to identify the baseline and estimate EEG activity. From Levy 
WJ. et al Automated EEG processing for intraoperative monitoring. 
Anesthesiology 1980;53:228. Reproduced with permission. 
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called a Compressed Spectral Array [30, 7] (Fig.2.31. A disadvantage of 
this technique is that finer details of previous spectra can become 
invisible when a dominant peak in the power spectrum develops 
i Fig. 2.4) .The resultant compressed spectral array however is very easy 
for the detection of gross change over time. These techniques are 
employed by the Pathfinder II EEG Frequency Analysis Program (Nicolet 
Biomedical Instruments, Madison Wisconsin USA) used for the EEG 
study described in this thesis. 
A recent development in presentation of frequency spectral data is the 
Power Density Plot. In this plot spectral data are plotted horizontally as 
dots, where the spacing between dots is varied according to power. This 
plotting technique avoids some of the drawbacks of the spectral array 
with hidden line suppression. Also the power density plot can be 
recorded on a simple dot matrix printer. A way of further data reduction 
is to extract a single numerical parameter from the frequency spectrum, 
usually a percentile. This is the frequency below which a given 
percentage of total measured power lies. The 50 percentile has been 
described by Stoeckel and Schwilden under the name of Median 
Frequency [31 J. The 90 percentile was amongst others used by 
Stanski under the name of Spectral Edge Frequency [32], [33]. 
Changes in the EEG produced by anesthetics 
Introduction 
A large number of papers have been written about changes in EEG 
frequency content produced by drugs used in anesthesia. A summary is 
given below. 
Nitrous Oxide 
In concentrations below 70% Nitrous Oxide causes little change in the 
EEG other than some attenuation of alpha activity. With a unipolar 
frontal electrode mode of recording, fast activity at 30 Hz and above can 
be seen with N20 inhalation [34]. The importance of this fast 
oscillatory activity has yet to be established. 
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Halogenated volatile agents. 
The initial EEG response to halogenated inhalation anesthetics in the 
absence of N20 is an increase in amplitude and a shift in mean 
frequency to 10-20 Hz. In monkeys a shift of high voltage activity from 
occipital to frontal parts of the skull is seen at about 0.4 MAC. This 
pattern is probably related to the loss of consciousness [35]. As 
inspired concentration is increased beyond 1 MAC the EEG is 
progressively slowed. With Ethrane a convulsive EEG pattern is 
observed [36]. With deepest levels of Isoflurane anesthesia the EEG 
first shows burst suppression and subsequently becomes isoelectric 
[37]. 
Fentanyl, sufentanil, alfentanil. 
The EEG with fentanyl and sufentanil has mostly been studied in 
conjunction with the high-dose opiate technique employed in cardiac 
surgery. The overall pattern is a slowing of dominant frequency without 
much change in general amplitude. The Spectral Edge frequency has 
been shown to decrease linearly with increasing plasma concentration 
of alfentanil. There is, however, a significant hysteresis in this relation 
[38]. 
Barbiturates 
With increasing plasma concentration a characteristic pattern of 
changes in the EEG can be defined for the barbiturates. This is 
demonstrated for thiopental in a classical paper by Kiersey and 
Bickford [39]. They described five patterns with increasing depth of 
anesthesia. They could not show any influence on these patterns by 
curare up to a point where expired minute volume was reduced by 
50%. The description of the five EEG patterns is reproduced here from 
the original paper. 
"First pattern. This pattern is characterized by high-amplitude, fast 
spiky activity of mixed frequencies varying between 10 and 30 cycles 
per second with the predominant frequency near 20 cycles per second. 
Second pattern. This pattern is a complex of many frequencies but 
differs from the preceding because of the presence of predominantly 
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slower wave forms of very irregular contour and random ocurrence. 
There is also much variation in voltage, the larger and predominating 
waves representing close to 150 microvolts. Superimposed on these 
slower waves and occupying the intervals between them is a much 
faster activity rather spikey in character and irregular in amplitude. 
The frequency of this element is near 10 cycles per second and the 
amplitude is comparable to that seen in the first pattern. 
Third pattern. This is characterized by a progressive suppression of 
cortical activity taking the form of short periods of relative quiescence 
that separate groups or bursts of waves. These bursts are frequently 
made up of two distinct elements. The first appears abruptly and 
consists of a short series of high-voltage waves of a frequency usually 
found to be near 10 cycles per second and continuing for about one 
second; the second element follows immediately in the form of two or 
more slow waves at a frequency of near 2 per second and tailing off into 
the next suppression phase. 
Fourth pattern. The difference between this and the preceding pattern 
is the duration of the periods of cortical inactivity which are defined as 
lasting between three and ten seconds. 
Fifth pattern. In this pattern periods of inactivity do not appear more 
frequently than once every ten seconds and there is further reduction 
in the amplitude of the components which may, for all components, fall 
below 25 microvolts. The frequency of the waves is the same as that 
found in the active phases of the preceding pattern." 
Experience with thiopental infusions for reduction of elevated 
intracranial pressure has learned that with the highest plasma 
concentrations EEG becomes isoelectric. 
Propofol 
The influence of propofol on the EEG has been studied using various 
techniques of EEG analysis. 
One study employed the Cerebral Function Analyzing Monitor (CFAM). 
The CFAM calculates on line the relative power in the alpha, beta, delta 
and theta bands and displays this graphically. With this monitor a 
significant change in EEG power is only seen at the highest plasma 
23 
concentration. At the lighter stages of anesthetic depth there Is a 
decrease in percentage beta activity together with increases in relative 
theta and delta power [40]. Drug effects can also be observed in the 
Power Spectrum. The median frequency is one of the indicators that 
can be used [31]. 
Conclusion 
Not one uniform pattern of EEG change can be defined for all 
anesthetic drugs. Especially the lighter planes of anesthesia give rise to 
varying patterns. Deepening unconsciousness invariably leads to 
lowering of the dominant frequency and the deepest levels of anesthesia 
produce EEG silence sometimes alternating with bursts of activity 
"burst suppression". 
The EEG represents spontaneous electrical activity from central 
nervous system structures. Anesthesia as defined above is dependant 
on (absence of) processing of noxious stimuli in the brain. Therefore 
from a theoretical point of view evoked electrical activity should provide 
more information on the influence of anesthetic agents on central 
nervous system functioning. 
Evoked Potentials 
An evoked potential is the electrical response from the central nervous 
system to an externally applied sensory stimulus. Evoked potentials 
can not be recorded without the help of computing techniques. A 
response to a single sensory stimulus is not be discernible from the 
background noise - mostly EEG -. The most common form of improving 
the signal to noise ratio of an evoked potential is the technique of 
averaging multiple consecutive responses. In this way those parts of the 
recorded signal that have a fixed time relation to the stimulus become 
visible as the random EEG background noise averages out. 
Evoked potentials can be triggered from auditory, visual and 
somatosensory sources in the sensory system. In this thesis emphasis 
lies on intravenous techniques employing a continuous infusion of an 
opioid which suppresses perception of pain. We therefore chose to 
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study Somatosensory Evoked Potentials concentrating on the 
transmission of somatosensory stimuli. 
In a review of spinal cord monitoring Nash and Brown suggested the 
need to include the stimulus site, recording site and evoked potential in 
the nomenclature [41]. 
In accordance with their suggestion the method of evoked potential 
recording used in this thesis has been abbreviated as SCEP 
(Somatosensory Cortical Evoked Potentials). 
The Somatosensory Evoked Potential 
In the Somatosensory Evoked Potential waveform recorded from the 
scalp (SCEP) two parts can be distinguished: a rather constant first 
part called the specific complex which is believed to arise from the 
projection of sensory activity onto the cerebral cortex and a variable 
part arising from the spread and subsequent integration of sensory 
activity across cortical structures. 
For evaluation peaks and valleys in the signal are identified and 
labelled (Fig.2.5). The time from the stimulus to the labelled points is 
called latency. As a naming convention for points thus identified the 
label "P" for a positive deflection and "N" for a negative deflection is 
used followed by either a number indicating the order or the number of 
microseconds latency as a subscript. The amplitude is measured either 
for each peak with reference to the line of electrical neutrality or as a 
peak to peak value. 
Influence of anesthesia on Evoked Potentials 
Premedication. 
Morphine 10 mg intramuscularly or diazepam 10 mg orally were 
compared in a double blind trial with placebo. There was no difference 
between drug and placebo in effects on posterior tibial nerve SCEP 
[42]. 
25 
Fig. 2.5 
Inhalation anesthetics 
In doses in the clinical range the inhalation agents, halothane, 
enflurane and isoflurane, all increase latencies and to a lesser extent 
reduce the amplitude of the SCEP to stimulation of the median nerve 
[43]. Isoflurane also increases the latency and decreases the 
amplitude of the Cortical Somatosensory and Visual Evoked Potentials 
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[44]. Halothane 0.25-2.0% in combination with nitrous oxide has 
been reported to increase latency of all components of the SCEP to 
posterior tibial nerve stimulation. Especially the peaks after P30 were 
sometimes obliterated. Spinal Monitoring was possible in 9 1 % of 
patients [45]. 
Nitrous oxide 
Nitrous oxide by itself in concentrations up to 50% decreases the 
amplitude of SCEP more than 1 MAC of halothane, but has no effect on 
latency [46]. In one study in cats the effects of nitrous oxide on 
amplitude of Somatosensory Evoked Potentials was measured using 
chronically implanted electrodes in different parts of the brain. The 
cortical response was reduced by more than 40% with 75% inhaled 
concentration of nitrous oxide [47]. 
Narcotics 
The opioids can produce changes in latency and amplitude of SCEP 
[48]. Brain stem components of Auditory Evoked Potential are very 
robust and show little change over a wide range of dosage [49]. 
Barbiturates 
In dosages up to the point where the EEG becomes isoelectric 
Somatosensory and Auditory Evoked Potentials are still measurable. 
There are dose dependent changes in amplitudes and latencies [50]. 
Etomidate 
In one study using upper extremity Somatosensory Evoked Potentials 
etomidate increased latencies of N20 and P23 without alteration of 
latencies of N10 or N14 and increased the amplitude of P15-N20 and 
N20-P23 while the amplitude of N10 was unchanged and the amplitude 
of N14 was decreased [51]. 
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Propofol. 
Propofol seems to enhance the ampli tude of Somatosensory Evoked 
Potentials when compared with the ampli tude during ni t rous oxide 
inhalat ion [52]. 
Ketamine 
Ketamine enhances Somatosensory Evoked Potential ampli tude when 
preinduct ion and post induction values are compared. Addition of 
n i t rous oxide to a ketamine infusion anes thes ia reduces ampli tude by 
about 50% [53]. 
Conclusion 
The specific complex of evoked potentials is changed by anesthet ics and 
analgesics. Inhalation anesthet ics progressively depress evoked 
potentials with increasing concentrat ion and can obliterate components 
of evoked potentials. Especially components with longer latencies are 
subject to suppress ion by anesthet ic drugs . Nitrous oxide mainly 
influences ampli tude. Opioid analgesics cause a dose dependent change 
in ampli tude and an increase in latency of Cortical Somatosensory 
Evoked Potentials. 
Brain s tem components of the Auditory Evoked Potential are less 
influenced t h a n evoked potentials originating in higher par t s of the 
brain . 
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SUMMARY 
Twenty-seven patients received an alfentanll loading dose of 
100 pg-kg ' in two 50 pg-kg ' aliquots followed by a fixed rate infusion 
of 1 pg-kg '-min1. At clinical signs of response to surgical stimulus, an 
alfentanil dose of 1 mg was added. Patients were ventilated with a 
N 2 0 /0 2 mixture. Muscle relaxation was achieved with a vecuronium 
infusion. No other drugs were given during the procedure. Major 
orthopaedic or maxillo-facial surgery patients were studied. The 
duration of infusion was from 2-7 h (mean of 3.9 ± 1.6 h SD). In 25 of 
27 cases the anaesthesia was considered adequate and stable. A mean 
of two additional doses per patient were needed in 25 patients, with a 
range of zero to four doses in the group. This study supports the view 
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that after an appropriate loading dose a fixed-rate infusion of alfentanil 
at 1 pgkg ' m i n 1 can be given for up to 7 h to provide satisfactory 
stable analgesia without undue postoperative ventilatory depression or 
prolonged recovery in the majority of cases. 
Alfentanil, one of the potent modem opioids, has been shown to have a 
relatively short terminal elimination half-life because of a distribution 
volume that is five times smaller than fentanyl. It has an onset time of 
1-2 min which allows it to be used as a continuous infusion that can be 
varied and titrated to the clinical effect [1]. From the work published 
by Ausems and colleagues, there is evidence that a plasma 
concentration of 200-300 ng-ml"1 is adequate in most patients to 
suppress the response to surgical stimulus from superficial surgical 
procedures [2]. By using average pharmacokinetic parameters for 
alfentanil [3], [4] and a two-compartment pharmacokinetic model 
predictions of plasma concentration for given dosage schemes have 
been made [5]. In this simulation, an alfentanil 100 pg-kg"' loading 
dose immediately followed by a 1 pgkg ' m i n 1 infusion provided the 
best approximation to achieve rapidly and then maintain plasma 
concentrations above approximately 200 ng-ml'. The aim of the present 
study was to see if such an infusion can be useful in a clinical setting 
for the provision of background intra-operative analgesia with i.v. 
single-dose injections being used to treat transient, noxious stimuli. 
PATIENTS AND METHODS 
Twenty-seven patients gave their verbal consent to take part in the 
study which was approved by the local ethics committee. Patient 
characteristics are shown in Table 3.1. 
Patients received either no premedication or, if required, diazepam 
10 mg by mouth 1 h before the operation. Anaesthesia was induced 
with an alfentanil loading dose of 50 pgkg"1 body weight followed by 
vecuronium 100 pg-kg ' and thiopentone 2 mg-kg"1. The patients' 
trachea were intubated and the lungs ventilated mechanically with an 
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TABLE 3.1 
Patient data. 
Number In study 
Sex (M/F) 
Mean age (yrs) 
Mean weight (kg) 
27 
18/9 
42 (range 14-81) 
71 (range 50-96) 
N 2 0 / 0 2 mixture 70%/30% to an end-tidal C02 of 3.5-4.5 kPa. After the 
initial dose an infusion of alfentanil 1 pg-kg'-min1 was started. 
Immediately before the initial skin incision a second bolus of 50 Hg-kg ' 
was given, making a total loading dose of 100 pg-kg '. An infusion of 
vecuronium was started and the rate adapted to generate between 50% 
and 75% twitch depression. Whenever a rise in blood pressure and/or 
pulse rate of more than 10% above normal for the patient, or any other 
response to surgical stimulation, was noticed an i.v. dose of alfentanil 
(1 mg) was administered. Alfentanil and vecuronium were stopped when 
surgery was expected to end within 20 min. 
A 20-gauge teflon cannula was inserted into a radial artery and used 
for blood pressure monitoring and blood sampling. Blood samples for 
the measurement of alfentanil plasma concentrations were taken at 
various times throughout the procedure and recovery phase. Plasma 
levels were estimated using a radioimmunoassay technique [6]. One 
hour after the infusion had been stopped, an arterial blood gas 
estimation was done to quantify the degree of ventilatory depression. 
For the clinical evaluation of the technique we examined: (1) stability of 
anaesthesia as indicated by the number of supplementary doses 
needed; and (2) the speed and quality of recovery. For a 
pharmacokinetic evaluation plasma concentrations were used to 
determine the stability of the plasma concentrations at steady state. 
The distribution half-life for alfentanil has been defined by various 
authors as between 9 and 16 min [3], [4|, [7]. We therefore took the 
first sample 40 min past the time of the second loading dose as a 
definition of the starting point of steady state. We compared the 
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concentration at this point to the concentration at the time when the 
infusion was stopped. 
RESULTS 
Clinical stabiUty 
The mean duration of infusion was 3.9 ± 1.5 h (SD) with a range of 
1-7 h. Two patients were considered unstable when the use of frequent 
doses of alfentanil did not maintain blood pressure and/or pulse rate 
within 10% of normal for that patient. Other signs of autonomic 
stimulation also remained present. In these two cases an inhalation 
agent was added to the anaesthetic technique. In the remaining 25 
patients a mean of two supplementary doses (range zero to four) were 
given per patient. 
Recovery 
In the 25 patients receiving only alfentanil and vecuronium, no reversal 
drugs were used. All patients were able to answer simple questions 
within 10 min after N20 had been stopped (16.7 ± 10.7 min after the 
end of infusion). Ventilatory frequency at this stage was between 8 and 
12 breaths-min"1. Throughout the recovery period ventilatory frequency 
stayed above eight breathsmin "' and the depth of breathing was judged 
adequate in all 25 patients. Arterial PC02, 1 h after alfentanil infusion 
had been stopped, showed a mean of 6.07 (± 1.06) kPa. Twenty-three 
patients did not request analgesics within the first hour of recovery. 
The incidence of vomiting during the first hour of recovery was 100%, 
much higher than expected. 
Plasma concentration 
Mean concentration at the starting point of steady state was 
307 (±110) ng-ml1. Mean concentration just before the end of infusion 
was 284 (±103) ng-ml1. This difference was not statistically significant 
(P>0.05). 
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DISCUSSION 
Synthetic opioids such as alfentanil have little effect on the circulation 
over a wide range of plasma levels. Except for ventilatory depression, 
muscle rigidity, bradycardia and nausea/vomiting, they have few other 
side effects. This can make a general anaesthetic technique with a drug 
like alfentanil preferable to the use of inhalational agents in a number 
of cases. With the pharmacokinetic properties of alfentanil, a fixed-rate, 
continuous infusion technique should provide the anaesthetist with the 
advantages of a stable opioid effect and still allow a rapid recovery time. 
Such a regimen would, in principle, resemble the use of longer acting 
opioid analgesics since after establishing the infusion one would only 
need to treat responses to surgical stimuli with a single dose of 
alfentanil, which will have effect within 1 -2 min. 
We took as our starting point a theoretical prediction of the alfentanil 
loading dose and maintenance infusion rate needed to attain a desired 
steady-state plasma concentration of 200 ng-ml ' [5]. Redistribution of 
the loading dose that was given in two 50 pg-kg"1 increments will result 
in the lowest plasma concentration occurring about 45 min after the 
second loading dose. We took this as the point to assess the steady-
state alfentanil plasma concentratiion. Had any accumulation been 
present in our patients this would have shown up in the comparison we 
made between plasma concentration at this point and the 
concentration at the end of infusion. 
A remarkable observation was the relative stress-free, painless recovery 
period. This contrasts with our earlier experience with fentanyl for this 
type of surgery, where, much more frequently, analgesics had to be 
given within the first minutes after recovery. In this study no drugs 
with anti-emetic properties were given. Also, nasogastric tubes were not 
inserted in spite of some prolonged surgery. These factors might 
account for the unexpectedly high rate of nausea and vomiting we 
observed. Later experience indicates that the use of low-dose droperidol 
may prevent nausea without clinically prolonging recovery. 
We claim that with the alfentanil dosages used in the study one might 
expect to achieve a stable level of intra-operative analgesia in 90% or 
more of all cases with an acceptable rate of recovery and very little risk 
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of post-operative respiratory depression. In a small percentage of 
pat ients the combination of this dosage of alfentanll and N 2 0 may not 
be sufficient to obtain the desired stability of analgesia. 
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ALFENTANIL PHARMACOKINETICS DURING AND AFTER A FIXED 
RATE INFUSION 
Evaluation of the effects of dose, dura t ion of infusion, age a n d body 
weight. 
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SUMMARY 
Twenty-nine pat ients (age range 14-81 5т) undergoing orthopaedic 
surgery were administered 100 pg-kg"1 alfentanil given a s two i.v. 
boluses a n d followed by a fixed rate infusion of 1 p g k g ' - m i n ' for 
44-445 m i n u t e s . Additional 1 mg bo lus doses of alfentanil were 
administered a s required. Plasma samples were assayed for alfentanil 
using radioimmunoassay. Pharmacokinetic p a r a m e t e r s were estimated 
by a model-independent approach a n d by curve-fìtting. Regression 
analysis showed no statistical relationship between TVyS, CI or Vd and 
the durat ion of the infusion, total dose or body weight. We found no 
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significant correlation between age and Т'ДЗ of alfentanil for patients 
younger than 40 yr. For patients older than 40 yr, Т г£> increased 
linearly with age. There was no significant decrease in CI with age 
although the lower values for clearance (100-200 mlmin ') were 
generally found in subjects older than 60 yr. The present study 
demonstrated that a 100 pg-kg ' loading dose and a 1 pg-kg 'min ' 
infusion may be appropriate for analgesia in generad surgical 
procedures. 
INTRODUCTION 
Most information on the pharmacokinetics of alfentanil has been 
obtained after a single bolus injection to patients under general 
anesthesia [1-7]. Maitre [8] used data from four of those studies to 
calculate a set of average population pharmacokinetic parameters for 
alfentanil after a bolus injection using the NONMEM computer program 
[9], [10]. Sex, body weight and particularly age were noted to be factors 
affecting the disposition of alfentanil in the normal population of 
surgical patients without liver or renal function impairment. 
There are only few detailed pharmacokinetic studies of a continuous 
infusion of alfentanil, despite the clinical importance of this technique 
[11-131. Both Fragen and colleagues [11] and Shafer, Sung and White 
[12] used a 2-compartmental model in their kinetic analysis, whereas 
Reitz and coworkers [13] applied a model-independent approach. The 
pharmacokinetic parameters for alfentanil given by i.v. infusion were 
similar to those after a single bolus injection, but there were also some 
conflicting data. Based on a diminished clearance found in 2 of 11 
patients Reitz [13] claimed that the clearance of alfentanil decreased 
linearly with duration of infusion. Shafer [12] on the other hand did not 
find such a correlation. These conflicting findings may be a result of the 
small numbers of patients included in these studies. Only a few 
subjects older than 60 yr were included. We have therefore investigated 
a larger and population, using infusions of longer duration. 
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Using computer predictions based on averaged kinetic parameters, 
Noorduin and collegues [141 examined infusion regimens aimed at 
providing adequate peroperative analgesia whilst avoiding postoperative 
respiratory depression. Their recommendation for surgery under 
general anaesthesia was: a fixed rate maintenance infusion of alfentanil 
1 pg-kg'min"1 preceded by a loading bolus injection of 100 pg-kg'. 
This should give a therapeutically adequate plasma concentration, at 
steady state, of 300 ng-ml"1 [15]. The present study was designed to 
evaluate these predictions in a patient population with the widest 
acceptable age range and duration of major peripheral surgery. 
PATIENTS AND METHODS 
Twenty-nine patients (19 female) gave verbal consent to participate in 
the study, which was approved by the local ethics committee. All 
patients were ASA I or II without impairment of hepatic or renal 
function and were scheduled for orthopaedic surgery (Table 4.1). Mean 
age was 42 yr (range 14-81), mean weight 70 kg (range 50-96), mean 
duration of infusion 228 minutes (range 44-445). Mean total dose of 
alfentanil was 24.8 (range 10.1-45.3) mg. 
Patients received either no premedication or diazepam 10 mg by mouth 
1 hour before surgery. Anaesthesia was induced with an i.v. bolus of 
alfentanil SOpgkg 1 , vecuronium 100 pgkg ' and thiopentone 
2 mg-kg '. After tracheal intubation, the lungs were ventilated 
mechanically with 70% nitrous oxide in oxygen to an end-tidal carbon 
dioxide partial pressure of 3.5-4.5 kPa. An i.v. infusion of alfentanil 
1 pgkg'-min"1 was started immediately after the initial 50 pg-kg"1 bolus 
of alfentanil. A second 50 pg-kg ' alfentanil bolus was administered i.v. 
immediately before incision, in most cases approximately 30 minutes 
after the first bolus. An infusion of vecuronium was started and the 
infusion rate was adapted to give single twitch depression of 50-75%. 
An additional bolus of alfentanil 1 mg was given if an increase in 
arterial pressure or heart rate of more than 10% greater than baseline 
occurred or if the patient responded in other ways to surgical 
stimulation. The infusions of alfentanil and vecuronium were stopped 
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Table 4.1 
Patient data. 
Patient 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
mean 
min 
max 
Sex 
F 
F 
M 
M 
F 
F 
M 
F 
F 
F 
F 
F 
M 
M 
F 
F 
M 
F 
F 
F 
M 
M 
F 
M 
M 
F 
F 
F 
F 
Age 
(yr) 
70 
74 
32 
64 
15 
18 
71 
36 
58 
80 
58 
81 
33 
24 
48 
31 
24 
31 
26 
33 
15 
19 
14 
26 
41 
32 
42 
50 
59 
42 
14 
81 
Weight 
(kg) 
90 
68 
92 
61 
80 
55 
96 
56 
73 
75 
61 
80 
70 
92 
65 
73 
78 
56 
63 
75 
65 
58 
50 
80 
72 
70 
56 
50 
72 
70 
50 
96 
Duration of 
infusion 
(min) 
241 
173 
107 
230 
284 
129 
178 
353 
131 
220 
216 
230 
44 
356 
133 
150 
398 
321 
237 
390 
101 
347 
287 
445 
173 
176 
183 
192 
175 
228 
44 
445 
Total 
dose 
(mg) 
33.1 
20.3 
18.8 
22.4 
33.5 
13.5 
22.6 
29.1 
17.8 
20.0 
21.5 
27.4 
10.1 
44.8 
15.4 
18.6 
41.4 
29.3 
21.8 
45.3 
12.9 
27.2 
24.3 
45.2 
21.4 
26.0 
16.7 
17.6 
19.9 
24.8 
10.1 
45.3 
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approximately 20 min before the end of the operation. 
Blood samples were obtained from a twenty gauge Teflon cannula 
inserted into a radial artery, immediately before the first bolus injection 
of alfentanil and at 5, 10, 20, 30, 45, 60 and every subsequent 30 min 
during the infusion; further immediately before and 3 and 5 minutes 
after each supplementary bolus; and finally 3, 10, 30, 60 and every 
subsequent 60 min for 8 h after cessation of the infusion. 
Analysis 
Concentrations of alfentanil in plasma were measured by a specific 
radioimmunoassay [16]. The detection limit of the assay was 1 ng-ml"1 
plasma. The accuracy and reproducibility of the radioimmunoassay 
were within 5%. Pharmacokinetic parameters were calculated by two 
methods: model-independent approach (MI) and curve fitting (FIT) using 
standard one-, two- or three-compartment analysis. 
In the model-independent approach, the terminal half-life (T'/iJS) and 
the pharmacokinetic parameters based on the area under the plasma 
concentration-time curve were calculated. TVyj was obtained as 
0.693/J5 where J3 is the slope of the terminal log-linear plasma 
concentration-time data. The total area under the plasma 
concentration-time curve (AUC0.J was estimated as AUC0.„ = AUC0.t + 
Ct/^ where AUC0.t was obtained using trapezoidal summation to the last 
plasma concentration (Ct). 
All plasma concentration-time curves of alfentanil were fitted to a 
standard multiexponential equation for a set of i.v. bolus doses and a 
continuous infusion [17]. Compartmental volume (Vc), α, β and k2 1 were 
obtained using extended least-squares nonlinear regression (ELSFIT) 
[18]. The appropriate compartmental model was selected by evaluation 
of the standard errors on the parameter estimates, scatterplots of the 
residuals between experimental and predicted plasma data and the 
maximum likelihood function. All other pharmacokinetic parameters 
were derived using standard methods [17]. 
The relationships between the relevant pharmacokinetic parameters 
and variables such as infusion duration, total dose, age and body 
weight were investigated by linear regression analysis [19]. 
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The estimated steady state concentration (the plasma concentration 
that would have been reached if the infusion had continued long 
enough for steady state to be attained) was calculated with the formula: 
Concentration = Infusion rate / Clearance. 
RESULTS 
Pharmacokinetic analysis 
The pharmacokinetic parameters obtained by the model-independent 
approach and by curve-fitting are listed in Tables 4.2 and 4.3, and the 
two-sided 95% confidence intervals (t χ SEM) for the mean absolute 
differences between both methods expressed as a percentage of MI είτε 
2-5% for CI and 8-15% for TVeß and Vd area (Table 4.4). 
The time course of the alfentanil plasma concentration was fitted to a 
two-compartmental model in 26 patients. The plasma concentration 
data of 3 patients (Nos 4, 7 and 18) could not be fitted adequately by 
any compartmental model. We were able to show in the 26 patients 
whose data could be fitted by both methods that there was no relevant 
difference between parameters found with our curve-fitting method and 
those found using a model-independent analysis. 
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Table 4.2 
Pharmacokinetic parameters derived by model independent approach. 
Patient 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
Mean 
SD 
TVeß 
(min) 
115 
155 
72 
226 
80 
78 
156 
94 
144 
134 
78 
185 
66 
70 
92 
90 
79 
99 
135 
94 
90 
90 
77 
91 
114 
96 
56 
112 
102 
106 
38 
Cl 
(mimin1) 
197 
107 
401 
99 
272 
194 
446 
321 
171 
172 
329 
198 
382 
457 
332 
305 
268 
181 
231 
197 
218 
258 
245 
178 
297 
440 
362 
340 
396 
276 
101 
Vdarea 
(1) 
32.8 
23.9 
41.5 
32.2 
31.3 
21.8 
100.6 
43.7 
35.6 
33.3 
37.2 
52.7 
36.4 
46.3 
44.1 
39.6 
30.4 
25.9 
45.0 
29.8 
28.2 
33.5 
27.2 
23.5 
48.9 
61.1 
29.5 
54.9 
58.5 
39.5 
15.9 
Table 4 . 3 
Pharmacokinetic parameters derived 
Pat VAa tV2$ k lO k l 2 
n r min min min"1 min ' 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
8.9 
6.8 
9.9 
10.3 
6.8 
12.4 
2.0 
13.9 
8.8 
15.2 
14.1 
13.8 
12.0 
19.8 
4.6 
18.5 
21.1 
22.8 
25.7 
22.3 
8.7 
4.5 
7.4 
2.4 
6.5 
12.4 
132 
193 
77 
83 
80 
94 
122 
151 
96 
229 
69 
72 
70 
106 
77 
140 
111 
95 
97 
92 
96 
83 
92 
55 
131 
106 
.025 
.019 
.038 
.024 
.030 
.029 
.046 
.015 
.031 
.014 
.026 
.027 
.025 
.020 
.054 
.021 
.018 
.014 
.018 
.022 
.027 
.055 
.047 
.076 
.059 
.033 
.042 
.068 
.024 
.028 
.051 
.020 
.265 
.024 
.036 
.025 
.014 
.015 
.020 
.010 
.082 
.012 
.010 
.008 
.006 
.006 
.039 
.084 
.039 
.173 
.043 
.018 
Mn 12.0 l ü b .Vói . і м э 
SD 6.5 39 .016 .057 
curve-fitting. 
k21 Ve Vd
s s
 Vd
a r e a
 CI 
min ' 1 1 1 mi-min'1 
.016 7.67 27.2 36.4 191 
.019 5.15 23.3 27.5 99 
.016 10.13 25.1 43.0 3 8 5 
.024 11.78 25.8 33.5 280 
.029 6.27 17.2 21.9 191 
.014 
.043 
.015 
.018 
.010 
.019 
.018 
.023 
.011 
.025 
10.92 
4.11 
11.25 
10.27 
13.62 
15.96 
17.15 
13.26 
15.11 
5.14 
26.4 
29.6 
29.5 
30.6 
47.3 
28.1 
31.4 
24.6 
28.5 
21.9 
43.4 
33.6 
37.6 
43.7 
61.8 
42.0 
47.5 
33.3 
47.4 
31.2 
321 
191 
173 
316 
187 
421 
456 
332 
309 
280 
.009 
.011 
.016 
.011 
.011 
.021 
.023 
.015 
.047 
.010 
.011 
11.58 
11.23 
15.55 
14.73 
11.47 
6.53 
5.50 
9.69 
4.85 
6.10 
11.99 
28.0 
20.7 
23.4 
22.2 
17.9 
18.3 
25.2 
35.0 
22.6 
33.5 
31.8 
49.9 
32.5 
30.2 
36.5 
33.3 
24.3 
36.2 
60.6 
29.1 
67.6 
60.6 
248 
203 
220 
262 
251 
176 
304 
456 
368 
358 
395 
. u i a l u . z / 2b./ 40.2 284 
.009 3.89 6.3 12.0 9 5 
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Table 4.4 
Comparison of pharmacokinetic approaches. 
Mean difference and mean absolute difference between the Model 
Independent (MI) and the curve fitting (FIT) approaches expressed as a 
percentage of MI value. 
J " MtFIT
 ι00χ 1i f \MI-FIT\ 
Parameter 
tVisß (min) 
Cl (mlmin"') 
V d « . (1) 
Mean difference 
(95% conf. lim. = 
2 χ SEM) 
-5.5 (-10.9; -0.1) 
-1.3 (-3 .1; 0.5) 
-6.4 (-11.4; -1.4) 
Mean absolute difference 
(95% conf. lim. = 
2 χ SEM) 
11.3(7.8; 14.8) 
3.3 (2.0; 4.6) 
10.9 (7.5; 14.3) 
N=26 
There was a wide variation in TVfejS values which ranged from 56 to 
226 min. The highest values were mostly found in the age group older 
than 60 yr. 
Effects of dose or duration of the infusion 
The duration of the infusions ranged from 44 to 445 min. Total dose 
ranged from 10.1 to 45.3 mg. There was no significant correlation 
between the pharmacokinetic parameters (TVfcJS, CI ,Vc, Vd
ss
, Vd-^J and 
the duration of the infusion, or with the total dose including all 
supplementary i.v. bolus doses. 
Effects of body weight 
There was also no significant relationship between clearance or volume 
of distribution and body weight. 
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Effects of age 
Vdss was significantly enlarged with increasing age (P=0.003). 
Clearance did not correlate significantly with age (P=0.16). Age had a 
linear effect on Т УЗ in the patients older than 40 уг (P=0.0006). A 
correlation was not shown in the patients younger than 40 yr (P=0.74). 
Steady state concentration 
The mean estimated steady state concentration was 
293 (SD 132) ng-ml ' (range 147-636 ng-ml '). 
DISCUSSION 
Our kinetic parameters correlate well with values obtained in earlier 
studies after a single dose [1-7] or an infusion [11-13]. The average TVaß 
was in the order of 2 h and CI was approximately 4 ml kg 'min ' in 
young to middle-age subjects. In the present study, 26 patients were 
fitted to a two-compartmental model and 3 patients could not be fitted 
adequately to any compartmental model. 
Plasma concentrations after a single bolus injection can usually be 
fitted to a two-compartmental [3-5] or to a three-compartmental model 
[1],[2]. However it is well known that after cessation of an infusion the 
initial, fast distribution phase is reduced and is discriminated less 
easily in the total plasma concentration-time profile. This could explain 
why a three-compartmental model did not improve the fit over a 
two-compartmental analysis in the present study or in any other 
infusion study of alfentanil [12].[13]. Shafer, Sung and White [12] found 
no correlation between clearance and duration of infusion and reported 
also that the pharmacokinetics were independent of the maintenance 
infusion rate (0.25-1.3 pgkg ' -min ' ) , duration of the infusion 
(59-385 min), body weight (40-113 kg), age (18-59 yr), sex or type of 
surgery (superficial or intra-abdominal). In contrast Reitz and collegues 
[13] claimed there is a decrease in clearance and a prolonged half-life 
with increasing duration of surgery. Visual inspection of their published 
data reveals no correlation in the nine patients undergoing surgery for 
less than 150 min and an increase in ТУг.б and a decrease of CI in 
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only 2 patients with surgery lasting for 212- and 335 min respectively. 
The present study shows that the pharmacokinetics of alfentanil given 
by i.v. infusion are independent of the duration of the infusion (in the 
case of our study ranging from 44-445 min) and the total dose given 
(10.1-45.3 mg). Consequently, our data and those of Shafer do not 
confirm the conclusion drawn by Reitz. 
A factor known to change the disposition of alfentanil is age. Helmers 
[4] found prolonged TVzß and reduced clearance of alfentanil after a 
single bolus dose in the elderly. In addition, the population 
pharmacokinetic analysis by Maitre on single-dose data [8], which 
included the Helmers data from elderly patients, revealed age-related 
reductions in clearance and a slower redistribution from the deep 
compartment. With an alfentanil infusion Shafer's group [12] found no 
correlation between age and pharmacokinetic parameters, but it has to 
be stressed that the ages of their patients ranged from 18 to 59 yr. 
Scott and Stanski [20] reported increased TV^ JS with age but they did 
not find clearance values significantly affected by age. It should be 
noted that a very short infusion of alfentanil 1500 pg-min"1 was given 
for about 5 min and these data should be considered rather as a slowly 
given bolus than as a continuous infusion. Our findings are similar to 
those of Scott and Stanski [20], with Τ'/ίΐβ increased significantly in 
subjects older than 55 yr, but no significant linear correlation between 
clearance and age. One reason for the lack of correlation with clearance 
is probably that this tends to be more variable during a continuous 
infusion in long-term surgery than after a single bolus injection. 
Both the loading dose and maintenance infusion rate in this study were 
calculated on the basis of body weight as is conventional practice. The 
population pharmacokinetic analysis after a single bolus dose by Maitre 
revealed a significant effect of body weight on the volume of distribution 
of the central compartment but not on clearance. In our study, plasma 
clearance and volumes of distribution (Vdss and Vdarea) did not 
correlate significantly with body weight. 
According to the findings of Ausems and colleagues [15], for adequate 
pain relief the concentration at steady state should be In the order of 
SOOngml 1 . The mean value of the calculated alfentanil steady-state 
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concentrat ion in our s tudy averaged 2 9 3 ng-ml ' It indicates tha t the 
proposed 100 pg-kg ' loading dose and a n infusion of 1 pg-kg ' m m ' 
might be considered a s a n appropriate regimen for analgesia in general 
surgical procedures As in the presen t s tudy, t ransient periods of 
inadequate analgesia (indicated by hypertension and tachycardia) may 
be t reated by the use of additional iv bolus doses of alfentanil 1 mg. 
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SUMMARY 
An anaesthet ic technique for surgical procedures on the vertebral 
column is described consisting of a cont inuous infusion of a shor t 
acting opioid, alfentanil, and a muscle relaxant, vecuronium, in 
combination with ventilation us ing a n i t rous oxide/oxygen mixture. It is 
shown tha t the two s tandard forms of spinal monitoring: wake-up 
testing and somatosensory cortical evoked potentials can be employed 
effectively unde r this anaesthet ic technique. Wake-up testing was 
performed in 23 pat ients . Average wake-up time was 10 minutes 
(SD 3.7 min). Evoked responses suitable for spinal monitoring could be 
obtained in 60 of 61 pat ients . 
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INTRODUCTION 
Major spinal surgery is associated with the risk of neurological damage 
[1]. The consequences of spinal trauma can be kept to a minimum if 
functional damage is detected during surgery. Cases have been 
described in which corrective surgical measures were taken in response 
to a positive spinal monitoring test resulting in complete recovery of the 
patient without neurological deficit [2], [3]. Two monitoring methods are 
currently in general clinical use for intraoperative detection of spinal 
cord damage. The first method is known as the wake-up test. It was 
first described by Vauzelle in 1973 [4]. This test employs voluntary 
movement of the patient to command. The second method uses the 
technique of somatosensory evoked potentials to monitor viability of 
spinal cord function [5]. A pure motor function test using magnetic 
transcranial stimulation of the motor cortex has been described [6]. 
With peripheral EMG recording this form of stimulation might in future 
prove to be a better solution for the spinal monitoring problem, but at 
present this method cannot be considered for a routine monitoring. 
In a recent review of spinal cord monitoring Nash and Brown suggested 
the need to include the stimulus site, recording site and evoked 
potential in the nomenclature [5]. 
In accord with their suggestion the method of evoked potential 
recording used in this study has been abbreviated as SCEP 
(Somatosensory Cortical Evoked Potentials). 
Alfentanil is a potent short-acting opioid with considerable hypnotic 
activity. It has been shown to have a short elimination half life without 
postoperative respiratory depression even after prolonged periods of 
continuous infusion [7], [8]. Stable adequate surgical analgesia can be 
obtained in most patients using a bolus injection followed by a 
continuous infusion in combination with nitrous oxide [9]. This 
technique gives a level of anaesthesia that can be changed rapidly as is 
required for wake-up testing. One case of successfull wake-up testing 
under continuous alfentanil anaesthesia has been published [10]. 
Opioids especially when given by infusion have less influence on 
cortical activity when compared with inhalational agents, thereby 
allowing cortical SCEP to be recorded during opioid anaesthesia [11], 
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[12]. Nitrous oxide tends to reduce SCEP amplitude but the response 
remains measurable [13]. 
The aim of the present study was to assess if both methods of 
monitoring intact spinal cord function can be applied during an 
anaesthetic technique with a continuous infusion of alfentanil and 
ventilation with a nitrous oxide/oxygen mixture. 
METHODS 
Table 5.1 
Patient data. Values are given as Mean (Min/Max.SD). 
Number 
68 
Age 
(yr) 
29 .5 (5 /60 ,13 ) 
Duration of surgery 
(min) 
226 (101 /390 ,87 ) 
Total alfentanil 
(mg) 
24.5 (12.9/45,8.7) 
68 patients were included in the study for which local ethical 
committee approval had been obtained. All patients were to undergo 
thoracic or lumbo-thoracic spinal fusion for scoliosis or trauma (2 
patients). Relevant patient data are given in Table 5.1. In 7 patients 
spinal monitoring consisted of wake-up testing alone, in 16 patients 
both tests were used and in 45 patients SCEP alone. The choice of 
monitoring type was made after consultation with the surgeon and was 
based on the preoperative severity of the deformity. 
Preoperatively, patients were fully informed of the monitoring method to 
be used and gave their verbal consent. 
Anaesthetic technique 
Premedication consisted of 10 mg diazepam given orally 1 hour before 
induction. Alfentanil 50 pg-kg ' was given iv for induction, followed by 
thiopentone 2 mg-kg ' and vecuronium 100 pgkg V Anaesthesia was 
maintained using a continuous infusion of alfentanil 1 pgkg 'min'1 . A 
bolus injection of 50 pg-kg ' iv was given 1 minute before incision, thus 
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bringing the total loading dose of alfentanil up to 100 pgkg '. A 
continuous infusion of vecuronium was started. The patients were 
ventilated with nitrous oxide/oxygen 70/30% to an end-tidal PC02 
between 4.0-5.0 KPa. When there was a response to surgical 
stimulation, indicated by a rise in blood pressure and/or pulse rate of 
more than 20% above steady state level, a 1 mg bolus of alfentanil was 
given. 
Monitoring 
Monitoring consisted of ECG, intra-arterial blood pressure through a 20 
gauge needle inserted in the radial artery, skin and core temperatures, 
FIo2 and ETco2 measurement. Train of four stimulation of the ulnar 
nerve was used to monitor neuromuscular transmission. Resulting 
twitches of the adductor pollicis muscle were palpated and the 
administration of neuromuscular blocker was adjusted so that only two 
twitches were palpable. 
Somatosensory SCEPs were recorded using a Nicolet Pathfinder II 
system. Stimulation was provided by a constant current applied 
through skin electrodes to the popliteal nerve at the back of the knee or 
the posterior tibial nerve at the ankle of the left and right legs. Only one 
leg was stimulated at a time. For preoperative SCEP a current of 2 
times sensory threshold with a pulse duration of 200 microseconds and 
a repetition rate of 2.7 sec ' was used. Intraoperatively stimulus current 
was increased to 30 mA. Ten millimeter tinned disk electrodes were 
used in a Cz'-Fpz montage according to the international 10-20 system. 
Electrode impedance was kept below 4000 Ohm. A large surface 
electrode on the upper leg was used as ground. Sensitivity of the 
amplifier was set at 100 pV full scale. High and low pass filters were set 
at 5 and 1500 Hz respectively. The timebase was 200 msec (512 data 
points). The number of sweeps averaged was 300. 
Each patient was used as his own control. A SCEP shortly after 
induction of anaesthesia, before the start of surgery after the second 
loading dose of 50 pgkg 1 alfentanil served as control. Specific complex 
amplitudes and latencies were compared to evaluate sensory pathway 
conduction. We defined the specific complex as the first positive peak in 
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the 25-45 msec window (P35) followed by a negative peak (N45). A 
reduction in peak-peak amplitude of more than 50% or an increase of 
latency by more than 10% was taken as an indication of potential 
neurological damage. 
To perform a wake-up test the infusions of alfentanil and vecuronium 
were discontinued. In one case reversal of neuromuscular block with 
edrophonium was necessary. After 8 minutes with 4 twitches palpable 
nitrous oxide was discontinued and the patient ventilated with 100% 
oxygen. The patients name was then repeated once every 30 seconds 
followed by a request to move a hand until a first response was noted. 
Subsequently the patient was asked to move both legs and the 
response was checked. The anaesthetic was continued with 
nitrous oxide/oxygen 70/30%, a bolus dose of alfentanil 1 mg and 
vecuronium 2 mg and reinstitution of the continuous infusions of 
alfentanil and vecuronium. The time from discontinuation of the 
infusions till the first motor response of the hand was recorded as 
wake-up time. Blood pressure and pulse rate were recorded at the time 
of interruption of the infusion and at the time of response to command. 
Change in pulse rate and blood pressure is calculated as a percentage 
of the last value before discontinuation of the infusions. 
All patients were checked for signs of neurological damage 24 hours 
after the operation. The patients were also asked on this occasion if 
they remembered anything of the wake-up test. 
RESULTS 
It was possible to obtain intraoperative SCEP recordings suitable for 
spinal monitoring in 60 out of 61 patients. In one patient for reasons 
that could not be explained no reproducible SCEP recordings could be 
obtained pre- as well as peroperatively although the patient had no 
preoperative neurological symptoms. In this case only wake-up testing 
was used for spinal cord monitoring. 
The mean peak-peak amplitude of P35-N45 was 0.73 pV (sd 0.53) for 
the first SCEP after induction of anaesthesia. A satisfactory response 
was obtained in all cases where wake-up testing was performed. During 
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Table 5.2 
Results of the Wake-up test. Results are given as Mean (Min/Max.SD). 
Number 
23 
Time till w-up 
(min) 
10.4 (6/25,3.7) 
%Change HR 
27 (0/99,23) 
%Change Syst. 
bp. 
16 (4/30,9) 
the wake-up test the average increase in systolic blood pressure was 
16% and in heartrate was 27% (Table 5.2). The rate pressure product 
even during the awake episode remained less than 12.000 because the 
steady state pulse rate with alfentanil infusion is low. The average time 
till first response was 10.4 minutes (minimum 6 minutes, maximum 25 
minutes). In 6 cases spontaneous movement started before 
discontinuation of nitrous oxide (Table 5.2). 
In one case a change in SCEP shape intraoperatively was detected from 
the right leg with a signlncant reduction in P35-N45 peak to peak 
amplitude and an increase in the latencies, while the response from the 
other leg remained normal and the wake-up test was normal |Fig 5.1|. 
Because of normal movement during wake-up testing no surgical 
measures were taken. This patient showed dysaesthesia in the right leg 
postoperatively. Neurological examination suggested damage to the 
dorsal root of L5. Neurological symptoms gradually disappeared over 
the course of three months. One patient showed no movement of the 
left leg during the wake-up test while SCEP remained normal. 
Postoperatively there were no signs of neurological damage. Changes in 
SCEP fulfilling the criteria of potential neurological damage were seen 
in no other patient. No other postoperative neurological sequelae were 
seen in the first 24 hours postoperatively. 
Three out of 23 patients in the wake-up test group had some vague 
memory of the awake episode. One patient had more explicit memory of 
occurrences during the wake-up test. No experience of pain or anxiety 
was expressed by any of the patients. 
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Fig 5.1 
SCEP results from the patient with neurological sequelae. 
A. Pre Induction SCEP right leg. PINI amplitude 1. 4 ^ . PI latency 
30.8 msec. 
B. After surgical manipulation left leg. PINI amplitude 0.44/¿V. PI 
latency 32.4 msec. 
С After surgical manipulation right leg. PINI amplitude 0.24 /iV, PI 
latency З .8 msec. 
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DISCUSSION 
Several cases have been reported in the literature in which evoked 
potential monitoring failed to detect motor loss during surgery. This 
might partly be due to diflculty in interpreting the evoked potential 
signal especially when amplitudes have been reduced by anaesthesia 
and temperature loss. It is therefore recommended that wake-up testing 
should still be available even when SCEP monitoring is performed [5], 
[14]. According to Nash and Brown the wake-up test should still be 
considered as gold standard in spinal monitoring [5]. Any anaesthetic 
technique for vertebral column surgery should therefore allow 
intraoperative evaluation of spinal cord function with both methods. 
We chose to study spinal monitoring under alfentanil continuous 
infusion because in previous work it had been shown that with this 
technique a stable level of anaesthetic depth and of analgesia can be 
obtained in most cases with a fast and smooth recovery without 
prolonged respiratory depression [9]. We expected therefore to perform 
the wake-up test with only small changes in cardiovascular stability 
and to perform SCEP monitoring with predictable and acceptable 
changes caused by the anaesthetic. 
An alternative technique would employ an inhalation agent as 
anaesthetic during maintenance. With inhalation anaesthesia an 
additional difficulty would be introduced as the inhalation agent would 
cause a variable increase in latency of SCEP components [15] which 
does not occur in our technique. In the group of patients described by 
Jones et al [3] a hypotensive technique with high concentrations of 
halothane was used (personal communication). This might explain why 
the authors after three trial cases of cortical recording abandoned this 
technique in favor of epidural recording. We could obtain reproducible 
SCEP's in 60 of 61 patients even after procedures of long duration - in 
one case as long as 7 hours using alfentanil. We saw a reduction in 
amplitude caused by alfentanil and particularly nitrous oxide [13]. This 
was partially counteracted by increasing the stimulus current in our 
patients. Because of this and of intraindividual variability in latency 
and amplitude of the SCEP we chose to use each patient as own control 
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comparing each SCEP to one recorded soon after the second loading 
dose of 50 pgkg ' alfentanil before the start of surgery. 
Our experience shows that at any time during alfentanil nitrous oxide 
anaesthesia a wake-up test can be initiated. It will take on average 10 
minutes before a patient may be successfully prompted to move. In 
dogs spinal cord compression was compatible with complete recovery if 
compression was relieved after 30 minutes [16]. It may therefore be 
expected that the delay in waking up with our technique would not 
endanger the chances of complete recovery when corrective measures 
are taken in response to a negative wake-up test. 
An interesting observation was that, when interviewed 24 hours after 
the procedure, only 4 out of 23 patients reported conscious recollection 
of the wake-up episode without memory of anxiety or pain. A wake up 
test could be seen as an acceptable episode of awareness, the 
awareness being positively confirmed by the patients correct response 
to verbal command. Our experience therefore supports the view, 
expressed for quite some time, that awareness can exist during 
anaesthesia without conscious recollection [17]. During the anaesthesia 
described in this paper awareness during wake-up testing did not 
cause memorable anxiety or pain in contrast with unintentional 
awareness. We presume that anxiety was reduced because: 
1. Adequate analgesia was provided by the alfentanil infusion. 
2. Patients could communicate by movement because of 
reduction of neuromuscular blockade. 
3. During the preoperative visit patients had been informed. 
CONCLUSION 
An anaesthetic technique with alfentanil infusion may be a good choice 
as an anaesthetic technique when spinal monitoring by recording of 
SCEPs and/or by wake-up testing is indicated. It is a safe technique 
both peroperatively and postoperatively. It does not prohibit clinically 
useful SCEP recording and it enables a smooth wake-up test without 
signs of pain. 
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CHAPTER 6 
DEPTH OF ANESTHESIA DURING ALFENTANIL INFUSION WITH 
NITROUS OXIDE 
Clinical assessment , alfentanil p lasma concentrat ion and 
somatosensory cortical evoked potentials. 
H. van Beem 
Department of Anesthesiology, University of Nijmegen, the Netherlands. 
SUMMARY 
Somatosensory Cortical Evoked Potentials were measured in 15 ASA I 
pat ients undergoing lower spinal surgery. The influence of the 
anesthetic technique -alfentanil fixed rate infusion and ni t rous oxide 
oxygen controlled ventilation- on the Evoked Potentials was s tudied. 
After induction ampli tudes fell by 50%. There was little change in 
latencies. Responses dur ing anes thes ia were variable without good 
correlation with clinical signs or alfentanil p lasma concentration t h u s 
prohibiting the use of this monitoring technique as a measu re of 
anesthetic depth. 
INTRODUCTION 
In a number of s tudies it h a s been shown tha t cont inuous infusion of 
alfentanil can be used as par t of an intravenous anesthest ic technique 
[1], [2]. During this type of anes thes ia depth of anes thes ia is not 
easily determined by clinical observation alone. Both insufficient depth 
opening the possibility of awareness and a n unnecessary deep level 
leading to prolonged recovery are potential hazards . Therefore the need 
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exists to find an indicator of depth of anesthesia not dependent on 
clinical signs like blood pressure and pulse rate. Neurophysiological 
monitoring in particular evoked potential recording has been shown to 
offer potential in this area [3]. In a review of spinal cord monitoring 
Nash and Brown suggested to include stimulus site + recording site + 
evoked potential in the nomenclature [4]. Following their suggestion 
the method of evoked potential recording used in this study has been 
named Tibialis Somatosensory Cortical Evoked Potential (TSCEP). 
From work by other authors and from our own experience we know that 
the primary complex of TSCEP remains measurable during intravenous 
anesthesia with alfentanil. Small shifts in latency and a reduction of 
the amplitude of the primary complex have been reported [5|, [6]. 
The influence of nitrous oxide is also mentioned in the literature [7], 
[8]. Here the main effect is a reduction in amplitude. The aim of the 
study presented here was to analyze the possibility of defining these 
changes of the TSCEP signal in terms of anesthetic depth. 
METHODS 
Anesthetic technique 
Premedication consisted of 10 mg of diazepam by mouth 1 to IVà hours 
before operation. 
Patients were induced with 50 pg-kg ' alfentanil, 100 pgkg ' 
vecuronium and 2 mg-kg"1 thiopental. Jus t before incision a second 
bolus of 50 pg-kg ' alfentanil was given, bringing the total loading dose 
of alfentanil up to 100 pg-kg ' . Patients were intubated and artificially 
ventilated with oxygen in nitrous oxide 40/60 %. Ventilation was 
adjusted to keep end-tidal Pco2 between 4.5 and 5.5 kPa. An infusion of 
alfentanil 1 pg-kg 'min ' was used to maintain analgesia. Muscle 
relaxation was maintained by an infusion of vecuronium 
0.8 pg-.kg'-min 1. A rise in blood pressure and/or pulse rate of 20% or 
more from the level at steady state was taken as a sign of insufficient 
analgesia. In that case a bolus of 1.0 mg alfentanil was given. Patients 
were kept warm with a warming blanket. 
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Monitoring 
The following parameters were monitored throughout the procedure. 
• ECG/heart rate. 
• Blood pressure vla 20G cannula in the radial artery. 
• End-tidal C02. 
• Neuromuscular relaxation by train of four stimulation of the 
ulnar nerve and manual assessment of adductor pollicis 
muscle contraction. 
• Oesophageal temperature. 
The patients were watched at regular intervals for sweating and tear 
formation. Observation was made of any sign of frowning or other 
movement in response to surgical stimulus. These observations 
together with blood pressure/pulse rate data were used to give a 
clinical assessment of depth of anesthesia. Absence of signs of 
autonomic stimulation was scored as "adequate". The same situation in 
the first 10 minutes after a bolus dose of alfentanil was scored as 
"deep". When a response to surgical stimulation was observed or when 
after termination of alfentanil infusion blood pessure was back to 
normal or above depth was scored as "light". 
10 ml blood samples were taken from the catheter in the radial artery 
at predetermined intervals and at moments of clinically significant 
changes in anesthetic depth for determination of alfentanil plasma 
concentration. The blood was centrifuged and the supernatant plasma 
was stored at minus 20 degrees centigrade until further assayed. 
Alfentanil plasma concentration was measured using a Radio Immuno 
Assay [9]. 
Evoked Potential Recording 
TSCEP recordings were made on a Nicolet Pathfinder II system 
equipped with a dual constant current stimulus unit. The posterior 
tibial nerve of the right ankle was stimulated transdermally with silver 
silver chloride pregelled baby ECG electrodes. The nerve was identified 
by motor response. Stimulus current was adjusted to twice the sensory 
threshold. Stimulus pulse duration was 200 microseconds, repetition 
rate 2.3 per second. The response was recorded from the scalp using 
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tinned silver cup electrodes filled with chloride electrode gel held in 
place with collodion. Impedance was kept below 4000 ohms. Locations 
Fpz and Cz' (two centimeters behind Cz), according to the International 
10-20 system, were used as positive and negative input to the amplifier 
respectively. A scalp electrode equidistant to Fpz and Cz' was used as 
ground. 300 sweeps were averaged with 512 datapoints per sweep over 
200 milliseconds. Whenever the patient gave his consent TSCEP was 
recorded in the awake, premedicated patient. 
Interpretation of TSCEP curves 
Individual TSCEP curves were measured with the Pathfinder II cursor 
according to the system described by Spehlmann [10] {Fig.2.5|. 
Latencies of identifiable peaks and interpeak latencies were calculated 
for each averaged response obtained. 
Each time a TSCEP recording was made, anesthetic depth was scored 
as light, adequate or deep. 
RESULTS 
Fifteen ASA class I or II patients without any known neurological 
symptoms were studied. Patient characteristics are given in table 6.1. 
Patients were fully informed of the monitoring technique to be used. 
They gave their verbal consent to take part in the study. All patients 
were scheduled for lumbar or lumbo-sacral spondylodesis. 
The pattern of alfentanil bolus doses was the same as we saw in an 
earlier study (Chapter 3) [11]. In the present group no cases of 
persistently unstable anesthesia were seen. 
Results of plasma concentration measurement, TSCEP parameters and 
clinical assessment are summarized in table 6.2. Statistical significance 
is only reached by the difference in amplitudes pre and post induction, 
not between depth levels during anesthesia. 
Only for the score "light" was there a significantly lower plasma 
concentration. Between "deep" and "adequate" there was no statistical 
difference in alfentanil plasma concentration. 
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Table 6.1 
Patient data. 
Patient 
n u m b e r 
1 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
11 
12 
13 
14 
15 
Mean 
SD 
Range 
Sex 
M 
F 
M 
F 
M 
F 
F 
F 
F 
F 
F 
F 
M 
M 
F 
Age 
(yr) 
61 
38 
31 
17 
31 
42 
3 3 
14 
3 6 
4 7 
77 
3 4 
4 3 
3 3 
6 4 
4 0 
17 
17-77 
Weight 
(kg) 
61 
6 0 
9 0 
3 6 
4 8 
52 
57 
42 
64 
64 
68 
64 
70 
7 3 
125 
6 5 
21 
36-125 
DISCUSSION 
Studies in conscious volunteers have indicated that Cortical Evoked 
Potentials can be used as a correlate of pain response [12]. However 
the late peaks in the TSCEP signal correlating with this type of 
response are in a majority of cases no longer recognizable in the signal 
after induction of anesthesia. 
The nervous sytem pathway the impulse travels by is assumed to 
consist of Αδ fibers, but not С fibers, the substantia gelatinosa and the 
associated spinal tracts, the thalamus and its cortical projections. It is 
the electrical activity of this cortical projection that is registered by the 
scalp electrodes of the CSEP monitoring system. The pathways involved 
in the conduction of the TCSEP include central nervous structures 
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Table 6.2 
The only difference which is statistically significant is pre- post induction 
amplitude 
Depth of 
anes thes ia 
[C] Alfentanil 
(ng-ml ') 
Latency N, 
Latency Pl 
Latency N2 
Latency P 2 
Amplitude Ρ,-Ν, 
Amplitude Pi-N2 
Amplitude P 2-N 2 
Awake 
0 
38.3 (2.0) 
45.8 (4.1) 
56.0 (5.6) 
69.1 (9.1) 
1.87 (1.02) 
1.49 (0.97) 
1.98 (0.97) 
Light 
166.3 (57.4) 
37.6 (5.1) 
46.8 (4.4) 
60.3 (8.5) 
77.7 (13.6) 
0.44 (0.36) 
0.71 (0.70) 
0.68 (0.84) 
Adequate 
291.1 (80.5) 
38.9 (4.8) 
49.6 (4.8) 
64.9 (9.6) 
83.3 (16.5) 
0.52 (0.36) 
0.80 (0.58) 
1.00 (0.74) 
Deep 
299.3 (44.8) 
42.4 (0.7) 
50.9 (2.3) 
70.8 (3.2) 
0.58 (0.37) 
1.30 (0.58) 
containing a large n u m b e r of m u opiate receptors [13]. Therefore we 
expected to see effects of opiates on the TCSEP. 
It h a s b e e n suggested t h a t somatosensory evoked potentials show 
changes dur ing anes thes ia t h a t are related to the response to surgical 
s t imulation. Sebel showed in 8 pat ients t h a t latency a n d ampli tude of 
the median nerve evoked potential complex change with increasing 
dosage of anesthet ic a n d with response to surgical noxious st imulation 
[14]. We found no correlation between TSCEP changes a n d clinically 
scored depth of anes thes ia so, we could not confirm this for TSCEP. 
The inhalat ion of n i t rous oxide does influence cortical evoked potentials 
[7],[8]. In t h e l i terature a n average reduct ion in ampl i tude of the SCEP 
of 5 0 % is quoted. The reduction found in this s tudy is somewhat larger. 
This might reflect a n additional effect of alfentanil. A minor par t of the 
pre-post induct ion difference in ampl i tude a n d latency m u s t be 
at t r ibuted to cooling because oesophageal t e m p e r a t u r e fell b u t never 
more t h a n 1.5 degrees centigrade. The biggest problem however in our 
s tudy was the variability in ampli tude a n d latency during anesthes ia a s 
can be seen from the s t a n d a r d deviation figures. This variability 
prohibits statistical evaluation of small changes in ampli tude that 
might be contr ibuted by alfentanil. The s a m e problem was noticed by 
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Kalkman et al with reference to the u s e of TSCEP for spinal monitoring 
[15]. Two explanations may be given for th i s observation. 
• The m u c h smaller ampli tude of the evoked potential will m a k e 
t h a t interference plays a relatively large role in changes in 
ampl i tude a n d latency. Fur thermore the visual evaluation of 
peaks a n d valleys becomes less accurate . 
• Nitrous oxide may through its differential influence on 
different p a r t s of the central nervous system have a 
destabilizing effect on the functional s t a t u s of the brain. 
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SUMMARY 
During epidural analgesia six pat ients were anesthetized with a 
cont inuous infusion of propofol 12 mg-kg '-hr'1 for 30 minutes . To 
determine the usefulness of EEG monitoring for the estimation of depth 
of anesthesia the Fourier transform of a four lead EEG was recorded 
together with blood pressure , pulse rate and propofol p lasma 
concentrat ion. Mean frequency correlated well with p l a sma 
concentration. Systolic blood pressure was also a good indicator of 
anesthetic depth. An indication of the ins tan t of loss and regaining of 
consciousness can be found in the EEG b u t the transit ion is not 
precisely defined. EEG Fourier analysis can assis t in the determination 
of depth of anes thes ia b u t it can not be used as the sole monitored 
variable. 
INTRODUCTION 
A good estimation of depth of anaes thes ia is needed during intravenous 
anaesthesia . This is particularly t rue when a cont inuous infusion of a 
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short acting hypnotic is used, because here anaesthetic depth can 
change rapidly. Classical clinical signs such as changes in blood 
pressure or pulse rate are often not linearly related to depth of 
anaesthesia and are therefore unreliable [1]. Both overdosage and 
underdosage could result. Overdosage may lead to unnecessary 
prolongation of effect or to unacceptable side-effects. Underdosage may 
lead to awareness with or without conscious recollection. Any 
measurement of depth of anaesthesia should therefore not only show 
deepening of the anaesthetic level, but should ideally also allow the 
detection of awareness. 
The use of Propofol as an intravenous anaesthetic during surgery under 
loco-regional analgesia with and without intubation has been 
documented. A two stage infusion of Gmg-kg'-hr1 followed by 
4 m g k g 1 h r 1 provided light sedation during spinal anaesthesia in 
unintubated patients. An induction bolus of 2.5 mg-kg'1 plus an 
infusion of 12 mg-kg '-hr ' was, however, not satisfactory for 
anaesthesia with intubation in patients with various types of regional 
block 121. [31. 
Schüttler and Schwilden have described the change in median 
frequency of the EEG frequency spectrum with a steady state propofol 
infusion [4]. After induction they used a computer feedback control 
system to monitor and maintain the level of anesthesia. Their paper 
focused on maintenance of steady state. Not much attention was given 
to induction and wake-up stages. The aim of the study presented here 
was to evaluate the usefulness of EEG analysis for estimation of depth 
of anesthesia throughout a full range of anesthetic depths during a 
continuous fixed rate infusion of propofol. 
METHODS 
Six patients gave their informed consent to take part in the study. All 
patients were ASA class 1. Patient data are given in Table 7.1. The 
study was performed during orthopedic surgery of the hip or femur. 
Premedication consisted of Diazepam 10mg by mouth l-2hr before 
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Table 7.1 
Patient data. 
Patient 
number 
1 
2 
3 
4 
5 
6 
Sex 
F 
M 
F 
M 
M 
F 
Age 
(yr) 
66 
6 8 
20 
58 
34 
77 
Weight 
(kg) 
67 
9 3 
60 
85 
82 
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operation. An 18G lumbar epidural catheter was inserted at the L3-4 
level. Epidural block was induced with Mepivacaine 2% plus adrenaline 
1:200.000 18-20 ml. Thirty minutes after epidural injection of the local 
anaesthetic the adequacy of the regional block was tested. 
Subsequently an infusion of propofol 12mg-kg'1-hr ' was started and 
maintained at that rate for 30 minutes. The infusion was stopped and 
the patient was allowed to wake up. The loss of the eyelash reflex was 
taken as induction time and first spontaneous opening of the eyes as 
wake up time. 
Respiration was monitored by observation of the patient and counting 
respiratory rate at regular intervals. 
Arterial blood samples for estimation of plasma concentration of 
propofol were taken at 1, 3, 5, 10, 30 minutes from the start of 
infusion. Further samples were taken at 1, 3, 5, 10, 15, 30, 45, 60, 
120, 210 minutes after cessation of infusion. The blood was centrifuged 
and plasma stored at -20 degrees centigrade until assayed by High 
Pressure Liquid Chromatography [51-
Four channels of EEG were recorded using Fl-Cl , Cl-Ol, F2-C2, 
C2-02 montage according to the international 10-20 system. The EEG 
was recorded and on-line analysed for 12 second epochs using a Nicolet 
Pathfinder II system with the Nicolet Frequency Analysis Program (FAP) 
(Nicolet Biomedical Instruments, Madison Wisconsin USA). 
Ampliflcation was adjusted to set the highest voltage just below full 
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range of the AD converter. High and low bandpass filters were set at 
1 Hz and 120 Hz respectively. The FAP allows simultaneous on line 
Fourier analysis of EEG on four channels. The power spectrum can be 
split into four bands and for each band mean frequency and total power 
are calculated. The four frequency ranges used as bands in this study 
were: 
A: 2.00-5.00 Hz 
B: 5.25-8.00 Hz 
C: 8.25-24.00 Hz 
D: 2.00-24.00 Hz 
In addition the FAP allows for the calculation of eight derived 
parameters for each epoch using any of the available band frequency 
and power parameters. We used this facility to calculate the power ratio 
of a high frequency band (C) against low frequency (A). All data are 
made available as an ASCII string for a serially connected printer. To 
facilitate further analysis of the on-line data we connected the serial 
port of the Pathfinder to the RS432 port of an Acom ВВС В 
microcomputer. A program written in BBC Basic mixed with assembly 
language was used to capture and store on disc the data from the 
Pathfinder. 
Blood pressure was monitored continuously with a calibrated 
transducer (Hewlett Packard) connected to an intra arterial cannula in 
the radial artery. Every 12 seconds systolic pressure and pulse rate 
were read by the Analog to Digital converter of the BBC computer and 
stored on disk together with the EEG data. 
All descriptions of EEG changes in this paper are from a unilateral 
central-occipital montage. In patients operated in the lateral position we 
chose the EEG recording from the upper side. In the other cases we 
chose the side with the least artefact. 
From the available spectral data single indices for description of EEG 
changes were derived. Indices tested were: 
• Total power of the EEG signal. 
• Mean global frequency. 
• Power in band A divided by power in band С 
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Correlation with the time course of plasma concentration and with the 
timing of clinical events was made graphically. Statistical evaluation 
was made for timepoints; loss of eyelash reflex, 15 minutes, 30 minutes 
(end of infusion), spontaneous eye opening. 
Where changes are compared statistically a test for repeated 
measurements is used. A value of p<0.05 is taken as significant. 
RESULTS 
Timing 
At induction average time until the loss of eyelash reflex was 6 (SD 3) 
min. Average time from cessation of infusion until first spontaneous eye 
opening was 31 (SD 7) min. 
Blood pressure 
All blood pressure changes were related to a control value taken from 
the average of five readings from the arterial line the minute before 
induction. In all cases the blood pressure steadily dropped from the 
start until the end of infusion. A typical case of the course of blood 
pressure against time is illustrated by Fig. 7.1. Blood pressure drop 
was statistically significant at 15 minutes and at 30 minutes. From the 
cessation of infusion at 30 minutes the blood pressure started rising 
again. At the time of spontaneous opening of the eyes blood pressure in 
all cases was still below starting level. 
Respiration 
In the course of the infusion breathing became shallower but not 
insufficient. There was no significant change in respiratory rate. 
EEG 
Mean frequency of the 0-24 Hz spectrum showed a reduction with the 
same time course as plasma concentration in all cases. A typical 
example is given in Fig 7.2. Mean power and the high/low frequency 
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ratio showed no useable correlation with the time course of plasma 
concentration and clinical events. 
DISCUSSION 
A single parameter derived from the EEG frequency spectrum -Median 
Frequency- has been shown to predict steady state anesthesia during 
propofol infusion. It was even used in a feedback loop [6]. The 
authors payed less attention to the assessment of induction and 
emergence of anesthesia. The aim of the present study was to evaluate 
EEG changes throughout a full range of depth of anesthesia. 
Clinical effects. 
Hypnotic effect. 
At 12 mg.kg '.hr ' in the unintubated patient propofol provides 
adequate anesthesia in combination with epidural block. 
Effect of propofol on blood pressure. 
All blood pressure changes were related to a control value taken from 
the average of five readings the minute before induction. This means 
that most of the drop in blood pressure caused by the epidural block 
had already taken place. In the setting of this study propofol 
significantly depresses systolic blood pressure. Thus the findings of this 
study prove that in the presence of an epidural block to Thl0-Th8 
propofol produces a dose dependent drop in blood pressure. 
EEG 
The visual analysis of a raw EEG signal is time consuming and takes 
substantial expertise. Therefore techniques have been developed to 
extract information from the EEG allowing ready interpretation of data 
by less experienced personnel. Such a technique is the Fourier analysis 
of the EEG. The frequency spectrum obtained by Fourier analysis can 
be presented in various forms as a simple display conveying simplified 
information about the EEG signal which becomes available in seconds 
[7]. 
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Attempts have been made to extract from the Fourier spec t rum an 
univariate descriptor to be used a s indicator of anesthet ic depth. The 
aim of the present s tudy was to test the usefulness of various 
calculated parameters from the EEG Fourier spectral analysis a s an 
estimate of depth of anaes thes ia through the widest acceptable range of 
stages of anaestheste t ic depth for propofol including induction and 
emergence. The papers describing EEG registration during propofol 
infusion all u se a different electrode montage. Apparently the changes 
produced by propofol are global throughout both hemispheres . 
The Fourier analysis used in this s tudy is based on the assumpt ion 
that the EEG signal is a constant process during a 12 second sampling 
period. T h u s it cannot be concluded whether bu r s t suppress ion was 
present a t the deepest levels of anaesthes ia . 
On the other side of the spectrum of anaesthet ic level the transit ion 
from awake pa t te rn to a pa t te rn with characterist ic changes in the EEG 
power spec t rum and from anaesthet ised pat tern to awake pat tern are 
not synchronous with clinical observation. There remains a time lag in 
the EEG power spect rum versus clinical observation. We conclude 
therefore tha t EEG Fourier analysis can be used for measur ing 
anaesthet ic depth during the sleep stage of propofol infusion. It is 
however not a reliable indicator of awareness during propofol 
anaesthesia . 
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CHAPTERS 
GENERAL DISCUSSION 
INTRODUCTION 
Rationale 
The a ims of th i s thesis share one general purpose. The results should 
improve t h e m a n a g e m e n t of intravenous general anesthes ia . During the 
adminis trat ion of a n anesthet ic the anesthesiologist c a n be compared 
with the feed-back, feed-forward controller in a closed loop (Fig.8.1) 
Fig 8.1 
Schematical diagram of the feedforward concept. From Anesthesiology, 
Feedback and Feedforward, 1988 Institute for Anesthesiology, Nijmegen. 
Reproduced with permission. Model predictions preset the controller. Model 
parameters are dynamically updated by results from physiological 
measurements. 
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[1]. The function of the controller in this context is to mainta in 
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optimum depth of anesthesia. This function is performed by 
manipulating dosage of drugs [2]. For successful feed-forward control 
a model of the controlled object is needed. Part of such a model is 
formed by pharmacokinetic and pharmacodynamic parameters. Thus to 
assume the role of such a controller the anesthesiologist needs access 
to variables indicating depth of anesthesia as well as a model of the 
pharmocokinetics of the drugs used. Therefore this thesis contains both 
the study of drug kinetics and the search for indicators of drug effect 
(anesthetic depth). 
Depth of Anesthesia 
The main object of general anesthesia is to produce a state of 
unconsciousness throughout a surgical procedure without awareness 
and without (memory) storage or conscious recall [3]. Research into 
an indicator of depth of anesthesia will only make sense given an 
accurate definition. Unfortunately despite numerous publications no 
clear definition of depth of anesthesia has emerged. Every attempt at 
defining the concept of depth of anesthesia ends with a description of 
adequate depth in terms of absence of responses -autonomic or 
(sub)conscious- to surgical stimuli together with complete lack of 
awareness [4]. Thus depth of anesthesia is defined in terms of an 
alteration in the functional status of the central nervous system. 
Monitoring of autonomous responses represented by changes in blood 
pressure and pulse rate, sweating and lacrimation has until today 
formed the backbone of anesthetic efforts to estimate depth of 
anesthesia. However the application of recently introduced powerful 
intravenous drugs means that awareness with or without recall can 
exist in absence of significant autonomous response. The isolated 
forearm technique has shed doubt on the adequacy of anesthetic depth 
during various anesthetic techniques. In this technique one forearm is 
excluded from the circulation to prevent paralysis by muscle relaxants. 
When the patient is verbally prompted to move his hand, purposeful 
movement can be observed while all other clinical signs would indicate 
adequate anesthetic depth [5]. In chapter 4 of this thesis a similar 
observation is made during wake-up testing. Patients gave proof of 
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being aware by obeying verbal commands, yet changes in blood 
pressure and pulse rate were moderate to absent. Also postoperative 
recall was absent in most cases. This emphasises the need for better 
methods of monitoring anesthetic depth. 
Clinical signs 
The studies with the alfentanil infusion technique involved a 
continuous infusion of vecuronium at such a rate that a train of four 
stimulation elicited at least two palpable twitches. Attempts of a patient 
to move spontaneously would have resulted in identifiable muscle 
activity. During our techniques of intravenous anesthesia, depth of 
anesthesia must have varied considerably as judged from plasma 
concentration and blood pressure/pulse rate data. Only at the instant 
of awakening was spontaneous movement observed. From this we 
conclude that spontaneous movement was not a consistent sign of 
depth of anesthesia. This contrasts with the isolated forearm technique 
of measurement of anesthetic depth. An explanation for this apparent 
contradiction might be that our patients had analgesia provided at all 
times. Had we been able to record muscle activity at an 
Electromyographic level we might have seen changes over the course of 
an anesthetic. 
Neurophysiological monitoring 
Adequate anesthesia by definition is associated with an absence of 
efferent response to surgical stimuli. The usual response to surgical 
stimuli during anesthesia involves processing of sensory input through 
structures in the brain. The centres involved -thalamus, limbic system, 
reticular formation- all have close interconnections with the cerebral 
cortex. Therefore monitoring cortical function, spontaneous- and 
evoked- should yield direct information about anesthetic depth. The 
research described in this thesis tries to define the contribution to 
measurement of anesthetic depth by well known neurophysiologic 
techniques: ElectroEncephaloGraphy and Somatosensory Cortical 
Evoked Potentials. Right from the start it was clear that until now no 
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single monitoring technique exists that can fulfil all criteria of the 'ideal' 
indicator of anesthetic depth as quoted from Sebel in Chapter 2 [6]. 
EEG 
The EEG is formed by the changes in electrical potential recorded 
between two electrodes placed on the scalp. Potential changes from 
individual cells form random patterns that tend to cancel out on scalp 
electrodes. The tracing we can see forming the EEG must be caused by 
more global synchronised potential changes in cells within the cerebral 
cortex. The changes in potential responsible for the signal that can be 
recorded from the scalp can not be action potentials. Action potentials 
last for about 1 msecond. Postsynaptic excitation and inhibition lead to 
depolarisation and hyperpolarisation respectively of several mvolts 
lasting for up to 100 msecond. Most likely the generators of the EEG 
are the pyramidal cells in the cortex. They are oriented vertically within 
the cortex. Their dendrites penetrate almost to the surface of the cortex. 
Currents flowing along these cells can therefore penetrate to the scalp. 
Rhythmicity appears to be dependent on interactions between the 
cortex and thalamus and the interconnections between the cortical 
cells. Activation of reticular formation leads to loss of rhythmicity, 
whereas depression of reticular formation leads to slow rhythmic waves 
in the EEG. Thus it is in theory understandable that the typical 
changes in functional state of the brain caused by anesthetics produces 
patterned changes in frequency and power of the EEG [7]. 
Somatosensory Cortical Evoked Potentials 
The generation of somatosensory evoked potentials is not fully 
understood. The stimulus intensity used for SEP's excites only the 
largest myelinated fibers in the peripheral nerve (cutaneous and 
subcutaneous somaesthetic and proprioceptive fibers and alpha motor 
axons). Literature suggests that transcutaneous stimulation to 
stimulate pain C-fibers may not even be possible without damage to the 
skin [8]. Cell bodies of the large fiber dorsal column sensory system 
lie in the dorsal root ganglia; their central processes travel rostrally in 
84 
ipsilateral posterior columns of the spinal cord and synapse in the 
dorsal column nuclei at the cervicomedullary junction. Second order 
fibers cross to the opposite side shortly after origination and travel to 
the primary receiving nucleus of the thalamus -the ventroposterolateral 
nucleus- via the medial lemniscus. Third order fibers continue from 
thalamus to frontoparietal sensorimotor cortex. The generator of evoked 
potential signal measured from the scalp lies in the cerebral cortex 
[9],[10]. This anatomical line of propagation explains how SEP 
waveforms can be recorded from the scalp even with the highest 
dosages of opioids. On the other hand the influence of the opioid on 
anatomical structures in the brain propagating SEP makes it 
theoretically probable that depth of anesthesia during continuous 
infusion with an opioid would be reflected by changes in CSEP. 
Changes in latency and amplitude must therefore be a result of effects 
of the opioid on the brain. 
RESULTS 
Alfentanil 
Clinical effects 
In chapters 2 and 3 we could confirm that a fixed rate infusion of 
alfentanil in combination with nitrous oxide can produce steady state 
intravenous anesthesia. A plasma concentration of 200-300 ng-ml ' is 
in most cases sufficient for stable analgesia with the type of surgery 
used in our patients. In chapter 2 we describe a stable cardiovascular 
state in 27 of 29 patients. The remaining two patients showed increases 
in blood pressure most likely due to insufficient analgesia. On average 
recovery was complete 16 minutes after the end of the alfentanil 
infusion. The kinetic parameters we found in our study described in 
chapter 3 support the view of alfentanil as a rapid acting drug. After 
cessation of a continuous infusion this concentration decreases initially 
with a half life of approximately 12 minutes. Given in a dose of 
100 pg-kg"1 alfentanil does not only have a strong analgesic effect but 
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also acts as a sedative making the patients virtually unresponsive to 
verbal command within 1-2 minutes [11] This might mean that 
alfentanil, although considered as mainly a μ receptor agonist [12] 
produces strong к receptor effects in the dose range mentioned. This 
capability of producing unresponsiveness makes alfentanil a suitable 
agent to be used in an intravenous anesthetic technique. 
Comparison with criteria for the "ideal" narcotic 
In the Introductory chapter 2 Moldenhauer and Hug were quoted with 
their entena for the ideal narcotic Chapters 2 and 3 desenbe features 
of continuous alfentanil infusion In a number of aspects alfentanil 
meets the points raised by Moldenhauer and Hug for the ideal narcotic 
Specificity and efficacy 
In our experiments with continuous infusion of alfentanil we have 
shown that it is an efficient analgesic. In most of the patients desenbed 
response to major orthopedic surgical stimulation was completely 
suppressed In animal expenments alfentanil had been described as a 
specific μ receptor agonist. From pharmacological studies we know that 
μ receptor effect is mainly analgesia and sedation is produced by к 
receptor stimulation Our patients became unresponsive after the initial 
bolus dose of 50 pg kg ' This indicates that alfentanil is not specific for 
the μ receptor but also binds with the к receptor. 
Without respiratory depression 
Alfentanil has a definite respiratory depressant side effect Within one 
minute after the initial bolus of 50 pg kg ' all respiratory activity 
ceased. In the recovery phase however we saw no significant respiratory 
depression as shown by normal blood gases one hour after cessation of 
the continuous infusion 
Without nausea 
In our expenence alfentanil nitrous oxide anesthesia was accompanied 
by a high percentage postoperative nausea and vomiting However no 
antiemetic drugs were used either in the premedication or 
peroperatively 
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Without intestinal cramping 
The studies in this thesis all involved spinal surgery. No observations 
about intestinal effects can be made. 
Fast onset and short duration 
Both our clinical study (chap 3) and our kinetic study (chap 4) support 
the view that alfentanil is a drug with a very fast onset and short 
duration of action without accumulation. In chapter 3 is described how 
onset of effect is a matter of seconds. The experiments of chapter 4 
show that even after infusion of several hours duration the terminal 
half life of alfentanil is very short compared to other opiates. Steady 
state plasma concentration results from a balance between elimination 
and infusion rate. We showed that elimination half life is age 
dependent. Therefore the shortest duration of effect will be guaranteed 
if age is taken into account when calculating steady state infusion rate. 
Non-addictive. 
The duration of administration of alfentanil in our experiments is too 
short to be able to judge the addictive potency of alfentanil. 
Lack of tolerance 
Over the time course of our experiments with a maximum duration of 
infusion of 7 hours we never needed to increase dosage for adequate 
analgesia. Also in other studies using alfentanil for intravenous 
anesthesia we found no mention of acute tolerance [13]. 
Somatosensory Evoked Potentials and alfentanil / nitrous oxide 
Recent literature shows that opiates administered directly intrathecally 
do not change Somatosensory evoked Potentials in awake humans 
[14]. In dogs it was shown by Swenzen and coworkers that 
sympathetic output in response to noxious stimulation of C-flbers is 
suppressed by much lower dosages of alfentanil than is needed to 
suppress response to Α-delta fibers [15]. It is this Α-delta fiber 
stimulation that is thought to be responsible for the Somatosensory 
evoked potential as we described earlier in this chapter. Therefore it 
might be expected that evoked potentials can be elicited under 
alfentanil infusion as we have seen in chapter 5 of this thesis. So it 
seems reasonable to expect changes in the SCEP to reflect the cerebral 
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system effects of alfentanil, not the spinal effects. In some studies 
alfentanil did produce measurable changes in amplitude and to a lesser 
extent in latency. In our study of chapter 6 general anesthesia was 
produced by alfentanil in combination with ventilation with an 
oxygen/nitrous oxide mixture. Amplitude changes and to a lesser 
extent latency changes ocurred. However variance was too large for 
these changes to be of use for the quantification of anesthetic depth. 
The location of depression of Somatosensory Evoked Potentials by 
nitrous oxide has recently been studied in cats. The results suggest 
that thalamo-cortical relay of sensory information is suppressed. At the 
same time reticular formation activity is enhanced [16]. This finding 
offers some explanation why nitrous oxide acts as a weak anesthetic 
but strongly suppresses cortical Somatosensory Evoked Potentials. In 
our study the effects of nitrous oxide on the brain obscured changes 
produced by alfentanil. Recent literature suggests that substituting a 
propofol infusion for nitrous oxide inhalation and ventilating the patient 
with an oxygen/air mixture produces a SCEP that is much less variable 
[17]. 
Propofol 
Clinical effects 
In chapter 2 we mentioned some properties an intravenous hypnotic 
should have. 
• Smooth induction 
• Fast recovery 
• No active metabolites 
• Specificity without side effects 
We compare these with our findings of chapter 7 using propofol in 
combination with regional anesthesia. 
Smooth induction. 
Propofol given at a rate of 12 mg-kg ' in combination with epidural 
block gives good anesthesia with a smooth induction.lt might be argued 
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that our dosage of propofol 12 mgkg '-hr'1 is rather high. De Grood and 
co-workers however have shown that to enable smooth intubation and 
ventilation without coughing 9 mgkg '-hr ' can be too low [18]. This 
illustrates that the dosage we used is within the clinically acceptable 
range. 
Fast recovery. 
The relatively high dosage used in our study explains why recovery was 
not as fast as described by other authors. 
No active metabolites. 
The literature mentiones as an advantage of propofol with respect to 
recovery that once the patient is awake recovery is more complete in 
comparison with other anesthetics [19]. This aspect was not subject 
of our study of chapter 7. 
Side effects. 
We also describe in chapter 7 a significant drop in blood pressure 
correlating with plasma concentration. In this respect propofol thus is 
not an ideal intravenous hypnotic. 
Given at the correct dosage propofol is an effective hypnotic. Clinically 
depth of anesthesia is difficult to predict between the stage of 
unresponsiveness and the instant of spontaneous response again. As 
we have shown in chapter 7 propofol effect on EEG can be used to 
monitor depth of anesthesia during steady state infusion. 
Neurophysiologic monitoring during propofol infusion 
The study reported in chapter 6 of this thesis shows that a steady state 
anesthesia by infusion of propofol is reflected by specific changes in the 
EEG power spectrum. The exact moments of loss and regaining of 
consciousness are not well predicted by EEG power spectrum analysis. 
Here EEG changes seem to lag behind clinical signs. Several causes 
may be postulated to explain this lack of sensitivity of EEG. 
• The Fourier spectrum and any derived parameters are 
calculated over epochs of EEG signal of a certain length (from 
one to several seconds). Thus changes cannot become visible 
until after at least one epoch. 
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The EEG only represents activity of certain classes of cortical 
cells. Global changes will be reflected in the EEG, but a local 
process like memory storage or thought processes may go 
unnoticed. 
PROBLEMS REMAINING 
The elimination of noise 
Especially in the operating theatre electrical interference is responsible 
for a high noise level in neurophysiological signals. This noise is only 
partly eliminated by the analog filtering techniques mostly employed. 
Other methods will have to be developed for prevention of noise and 
improvement of filtering of neurophysiological signals. Improvement can 
sometimes be achieved by stopping data collection during periods of 
diathermia interference [20]. 
Problems in evaluating Evoked Potentials 
Up to date most investigators use no other method of evaluation of the 
information contained in evoked potentials than the peak latency 
method. Especially in a noisy signal simple visual inspection of a curve 
can be inaccurate and ambiguous for the detection of a peak. Computer 
techniques for peak detection might improve this situation. The 
complex evoked potential signal contains more information with 
relevance to the effects of anesthetics than what is extracted by the 
peak latency method. Improvements are to be expected from novel 
techniques for computer analysis of the evoked potential signal [21]. 
These will include a posteriori artifact elimination and automatic peak 
detection. 
Time lag 
The introduction of fast computing power has made considerable 
improvement in the time needed to obtain a Fourier spectrum or an 
averaged evoked potential. Nevertheless detection of changes in cerebral 
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function lags behind real t ime. Novel techniques of da ta collection a n d 
processing will be needed to help solve this problem [21]. 
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CHAPTER 9 
CONCLUSIONS 
One single parameter representing "Depth of anesthesia" is not 
available. The concept of depth of anesthesia is based on the 
functional status of the central nervous system characterized by the 
abscence of awareness and the abscence of efferent response to 
surgical -nociceptive- stimulation. Any conclusion about the functional 
status of the central nervous system can only be drawn from a 
combination of observations and measurements of physiological 
parameters. Anesthesiologists are taught to draw such conclusions 
through a mixture of logical combination and intuition. For a more 
scientific approach of depth of anesthesia computer technology will 
provide a strong aid. Before computers can however start to support 
decision making in the clinical setting software has to be developed. 
Techniques like neural networking might in the future form a basis for 
the process of infering conclusions from large numbers of data collected 
from the patient. 
Plasma concentration and depth of anaesthesia are not the same. Even 
a good model incorporating the relationship between plasma 
concentration and concentration at the target organ -the receptor 
compartment- will not be adequate for predicting anesthetic depth. The 
concentration needed at the receptor for a stable anesthesia is not a 
constant, but depends on circumstances such as nociceptive input, 
presence of other anesthetics and other factors. 
The studies in this thesis employing neurophysiological monitoring 
show, that especially around the moment of spontaneous recovery of 
consciousness neurophysiological monitoring fails to indicate depth of 
anesthesia. Furthermore, from the literature it can be shown that 
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parameters derived from neurophysiological monitoring give different 
responses with different anesthetic techniques and drugs. 
The Potentials in propofol / alfentanil infusion technique have a higher 
amplitude after induction than before. In our study using nitrous oxide 
/ alfentanil we saw the opposite. Questions like these concerning basic 
neurophysiology will have to be solved before Somatosensory Evoked 
Potentials can be considered an indicator of depth of anesthesia. Other 
Evoked Potentials -for instance Auditory Evoked Potentials- might 
provide more information. Other techniques of analysing the 
information content of the signal might also contribute towards 
employaient as measurement of anesthetic depth. 
EEG frequency analysis shows a better potential for measuring the 
graded functional status of the central nervous system than SSCEP. It 
did, however, not allow precise determination of the time of 
spontaneous awakening. This is a crucial point in monitoring depth of 
anesthesia. Our patients should be guarded against awareness by all 
available means. 
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SUMMARY 
The anesthesiologist has to manage his patient by a continuous process 
of decision making about which drugs and gases to administer and in 
what dosages. These decisions are based on a concept of depth of 
anesthesia. In order to rationalise his actions the anesthesiologist 
needs a better definition of this depth of anesthesia and better tools to 
measure it. 
Chapter 1 describes the reasoning leading up to the aims of the study: 
1. Exploration of two intravenous anesthetic drugs. By testing a 
pure analgesic and a pure hypnotic in separate experiments, 
we try to show the clinical usefulness of both drugs in future 
intravenous techniques. This part of the work will give some 
answers to the question how well these drugs fulfil the criteria 
of steady state intravenous anesthesia. 
2. Testing the possibilities of using Neurophysiological 
monitoring for the assessment of anesthetic depth during 
these two types of intravenous anesthesia. 
3. Efforts to correlate three elements in the determination of 
anesthetic depth during intravenous infusion of these drugs: 
clinical signs, neurophysiological changes and plasma 
concentration. 
Chapter 2 gives an overview of the literature. A historical summary is 
given of the concept of depth of anesthesia. 
The development of intravenous techniques of anesthesia is followed 
from literature. The objectives of anesthesia are summarized as: 
• Analgesia 
• Unconsciousness 
• Muscle relaxation 
• Autonomic reflex suppression 
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Although no final definition of anesthetic depth can be found in the 
literature a working definition is given for the purpose of this thesis: 
Anesthetic depth is the degree of suppression of consciousness and 
responsiveness of the central nervous system to noxious 
stimulation. 
Existing methods of assessing anesthetic depth are discussed. Both 
observation and measurement of clinical signs and neurophysiological 
monitoring have been mentioned in the literature. Various techniques 
are described to extract a "depth of anesthesia" parameter from EEG 
and Evoked Potential monitoring. 
Finally a summary is given of the literature describing the influence of 
various anesthetics on EEG and Evoked Potentials. 
Chapter 3 describes a clinical assessment of the use of loading dose 
followed by a fixed rate continuous infusion of a short acting opioid 
-alfentanil- in combination with Nitrous Oxide / Oxygen ventilation and 
vecuronium muscle relaxation. In 25 of 27 patients a satisfactory stable 
anesthesia was obtained. The remaining two patients needed multiple 
additional bolus doses. 
Chapter 4 describes a study of the pharmacokinetics of alfentanil in the 
same regime as in chapter 3. Two methods of calculating half life and 
clearance arc compared: a traditional curve fitting method and a model 
independent approach. Both methods performed equally well. 
Regression analysis showed no statistical relationship between Т лЗ, Cl 
or Vd and the duration of the infusion, total dose, or body weight. We 
found no significant correlation between age and T'/^ß of alfentanil for 
patients younger than 40 yr. For patients older than 40 yr, TVfeJJ 
increased linearly with age. 
Chapter 5 describes the use of Tibial Somatosensory Cortical Evoked 
Potentials and wake-up testing during continuous alfentanil 
anesthesia. It is shown that these two forms of spinal monitoring can 
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be employed effectively under this anesthetic technique. Wake-up 
testing was performed in 23 patients. Average wake-up time was 10 
minutes (sd 3.7 min). Evoked responses suitable for spinal monitoring 
could be obtained in 60 of 61 patients. 
Chapter 6 describes a study to correlate clinical indicators of depth of 
anesthesia with alfentanil plasma concentration and Tibial 
Somatosensory Cortical Evoked Potentials. After induction amplitudes 
fell by 50%. There was little change in latencies. Responses during 
anesthesia were variable without good correlation with clinical signs or 
alfentanil plasma concentration thus prohibiting the use of this 
monitoring technique as a measure of anesthetic depth. 
Chapter 7 describes a study to test the use of EEG monitoring for the 
assessment of depth of anesthesia with the hypnotic drug propofol. 
Propofol is given as a fixed rate infusion of 12 mgkg '-hr'1. Patients are 
made analgesic by a lumbar epidural block for lower limb surgery. 
Mean EEG frequency correlated well with plasma concentration. 
Systolic blood pressure was also a good indicator of anesthetic depth. 
An indication of the instant of loss and regaining of consciousness can 
be found in the EEG but the transition is not precisely defined. 
Chapter 8 discusses the results of the studies against the background 
of the literature referenced in chapter 2. 
In chapter 9 some conclusions are drawn. Estimation of plasma 
concentration is helpful in establishing a model aiding the 
anesthesiologist in his decisions about depth of anesthesia. So is 
neurophysiological monitoring. However no single descriptor of depth of 
anesthesia can be found. 
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SAMENVATTING 
In hoofdstuk 1 wordt de gedachtengang weergegeven, die tot het idee 
voor dit proefschrift heeft geleid. Een anesthesist moet tijdens zijn werk 
de dosis van de geneesmiddelen bepalen. Hiervoor dient hij een beeld te 
hebben van de bereikte effecten van alle toegediende middelen tezamen. 
De laatste jaren zijn in de anesthesiologie intraveneuze middelen 
geïntroduceerd met een hoge specificiteit. Hiermee is het mogelijk het 
ideaal te benaderen om de verschillende elementen van een algehele 
anesthesie afzonderlijk te verzorgen. We onderzoeken in dit proefschrift 
twee van deze middelen, een pijnstiller en een slaapmiddel. 
De doelen van het in dit proefschrift beschreven onderzoek zijn als volgt 
gedefinieerd: 
1. De bruikbaarheid onderzoeken van de pijnstiller en het 
slaapmiddel in intraveneuze anesthesie technieken. 
2. De mogelijkheden onderzoeken van neurofysiologische technieken 
om anesthesie diepte te meten tijdens toepassing van deze twee 
middelen. 
3. Pogen een synthese te maken van drie elementen bij de bepaling 
van anesthesie diepte: Klinische waarneming, neurofysiologische 
meting en plasma concentratiebepaling. 
Hoofdstuk 2 bevat een overzicht en samenvatting van relevante 
literatuur. Een historisch overzicht van de ontwikkeling van 
intraveneuze anesthesie technieken. Een historisch overzicht van de 
ontwikkeling van het begrip anesthesie diepte. Er wordt ingegaan op de 
gewenste eigenschappen van een pijnstiller en een slaapmiddel voor 
anesthesie. Er wordt een afweging gegeven van intraveneuze tegenover 
inhalatie anesthesie. Er wordt ingegaan op de observaties, die de 
anesthesist leiden bij het vaststellen van de anesthesie diepte. 
Neurofysiologische technieken worden besproken. 
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De volgende definitie wordt gesteld voor gebruik bij het onderzoek in dit 
proefschrift: 
Anesihesie diepte is de mate van onderdrukking van het bewustzijn en 
van de reactie van het centraal zenuwstelsel op inwerking van 
beschadigende prikkels. 
Hoofdstuk 3 is een publikatie die de klinische aspecten beschrijft van 
een anesthesie techniek met continue infuus van de kort werkende 
pijnstiller alfentanil in combinatie met spierverslapping en beademing 
met een zuurstof / lachgas mengsel. Conclusie is dat in 23 van 25 
patiënten de techniek goed werkt en een stabiele anesthesie oplevert. In 
2 gevallen moet met korte intervallen alfentanil extra worden 
toegediend. 
Hoofdstuk 4 is een publikatie over de berekening van de opname, 
verdeling en uitscheiding van alfentanil over het lichaam aan de hand 
van de bepaling van de concentratie in plasma monsters. De anesthesie 
techniek is dezelfde als in hoofdstuk 3. Er worden twee 
berekeningstechnieken vergeleken. Geconcludeerd wordt, dat een 
stabiele plasmaconcentratie wordt verkregen met de toegepaste infuus 
techniek (dezelfde als in hoofdstuk 3). De twee berekeningstechnieken 
geven statistisch niet van elkaar verschillende resultaten. Op valt, dat 
de terminale halfwaardetijd bij patiënten boven de 40 jaar een lineair 
verband heeft met de leeftijd. 
Hoofdstuk 5 is een publikatie over de toepassing van dezelfde 
anesthesie techniek uit de hoofdstuk 3 bij wervelkolom chirurgie. Het 
blijkt, dat de gebruikelijke methoden om beschadiging van het 
ruggemerg op te sporen, SomatoSensore Evoked Potentials en 
ontwaaktest goed zijn toe te passen. Hiermee is aangetoond, dat 
SomatoSensore Evoked Potentials zijn te registreren tijdens alfentanil 
infuus met lachgas beademing. Op valt, dat met de ontwaaktest wordt 
bewezen, dat een patiënt gericht op vragen kan reageren tijdens 
anesthesie en dit na de operatie niet meer weten. 
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Hoofdstuk 6 beschrijft een studie naar de relatie tussen veranderingen 
in het SomatoSensore Evoked Potential signaal, de plasma concentratie 
van alfentanil en de anesthesie diepte. Zodra de patiënt onder 
anesthesie is gebracht neemt de hoogte van het Evoked Potential 
signaal af met ongeveer 50%. Variaties in grootte en tijdsrelaties in het 
signaal doen zich daama wel voor. Er is echter geen duidelijk verband 
met plasma concentratie en geschatte anesthesie diepte te vinden. 
Hoofdstuk 7 is een studie met een continu infuus van het slaapmiddel 
propofol voor anesthesie bij patiënten, die eerst complete pijnstilling 
hebben gekregen met epidurale verdoving. Bloeddruk en polsfrequentie 
werden gemeten en vastgelegd via een computer. Tevens werd tijdens 
anesthesie continu het Electro Encephalo Gram (EEG) geregistreerd en 
met een computerprogramma bewerkt. Op het EEG signaal is Fourier 
transformatie toegepast, waarna een aantal waarden uit het 
frequentiespectrum werden vastgelegd. Op gezette tijden werd de 
plasmaconcentratie van propofol bepaald. Er werd getracht uit de 
resultaten een patroon te vinden in verandering van EEG frequentie 
inhoud dat correleert met de verandering in anesthesie diepte en 
plasma concentratie. De gemiddelde frequentie uit het spectrum 
uitgezet tegen de tijd tezamen met plasma concentratie laat zien ,dat bij 
de aanvang van de anesthesie en in de diepe fase een verlaging van de 
frequentie optreedt, die een verloop heeft overeenkomstig de andere 
gemeten grootheden. De stap naar een hogere frequentie inhoud, die 
past bij ontwaken, wordt bereikt, nadat de patiënt klinisch tekenen van 
ontwaken heeft vertoont. 
Hoofdstuk 8 bespreekt de bevindingen uit de studies van hoofdstukken 
3 tot en met 7 tegen de achtergrond van de literatuur uit hoofdstuk 2. 
Hoofdstuk 9 trekt conclusies. Geen enkele van de toegepaste 
technieken van monitoring is geschikt gebleken om op zich zelf de 
anesthesie diepte mee te meten. Een bepaling van anesthesie diepte zal 
moeten volgen uit het combineren van klinische waarneming en een 
aantal fysiologische metingen. De getallen, die hieruit komen dient de 
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anesthesist te combineren met gebruikmaking van zijn ervaring. Uit dit 
proces volgt dan, ten dele intuïtief, een inschatting van anesthesie 
diepte. 
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STELLINGEN 
behorende bij het proefschrift 
Depth of Intravenous Anesthesia 
H.B.H, van Beem 
1. De infusiesnelheid tijdens een steady state infuus met 
alfentanil dient aangepast te zijn aan de leeftijd bij 
patiënten boven 40 jaar. (Dit Proefschrift) 
2. Wanneer bewaking van de ruggemergsfunctle tijdens 
wervelkolom-chirurgie wordt toegepast, verdient een 
totaal intraveneuze anesthesietechniek de voorkeur. 
(Dit proefschrift) 
3. De toestand "onder anesthesie" is een vloeiende, 
constant veranderende beïnvloeding van de functionele 
toestand van het centraal zenuwstelsel, geen on-off 
fenomeen. (Bonke B. ed. Memory and awareness in 
anaesthesia. Swets & Zeitlinger bv, Amsterdam 
1990:73) 
4. Voor bepaling van de anestheslediepte dient een 
combinatie van een aantal waarnemingen en metingen 
aan de patiënt te worden verwerkt met de ervaring van 
de anesthesioloog. 
5. Dat artsen vaak onbekend zijn met het bestaan van niet 
opiaat-gevoelige pijn is de oorzaak van veel onnodig 
lijden bij kankerpatiënten. 
6. Regelgeving is nodig om wildgroei te voorkomen bij 
facilitaire ondersteuning thuis voor patiënten die 
behandeld worden met continue spinale infusie. 
7. In principe verdient biologische reconstructie van 
beschadigd gewrichtskraakbeen de voorkeur boven 
herstel met een prothese. 
8. Gecontroleerde hypotensie tijdens het inbrengen van 
een gecementeerde heupprothese kan de penetratie van 
het methyl-metaciylaat in trabeculair bot bevorderen. 
9. Surgery begets surgery. 
10. Sommige regels in het Wegen Verkeers Reglement 
dienen niet zozeer de verkeersveiligheid als wel de 
belangen van handelaren in tweewielers. 


